Podcasts about Cochrane

  • 1,232PODCASTS
  • 3,457EPISODES
  • 29mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Mar 3, 2026LATEST

POPULARITY

20192020202120222023202420252026

Categories



Best podcasts about Cochrane

Show all podcasts related to cochrane

Latest podcast episodes about Cochrane

Sigma Nutrition Radio
#596: Why Do Omega-3 Trials Show Mixed Results?

Sigma Nutrition Radio

Play Episode Listen Later Mar 3, 2026 66:11


Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial literature is often perceived as inconsistent. This episode examines why some randomized trials show clear benefit while others show null or mixed findings, and how differences in trial design, dose, population risk, and outcome selection can materially change what we observe. A key theme is separating (1) the persistent cultural narratives around omega-3s (including origin stories that do not hold up well to modern evidence) from (2) the more precise, mechanistic and clinical questions about where supplemental EPA/DHA may reduce cardiovascular risk. The discussion focuses heavily on understanding heterogeneity: why "omega-3 supplementation" is not a single, uniform exposure, and why subgroup patterns (e.g., secondary prevention, higher baseline triglycerides, and higher doses) may explain much of the apparent conflict in the evidence. Note: This discussion is taken from a previous episode of the podcast. The audio has been remastered and improved, and now study notes and full transcript are available. Timestamps [04:10] Omega-3 historical context and Inuit studies [08:38] Mechanisms of omega-3 benefits [12:49] VITAL and ASCEND trials analysis [23:41] GISSI-Prevenzione trial insights [26:44] REDUCE-IT trial and residual risk [32:19] Significance of baseline triglycerides [37:57] 2018 Cochrane review [46:02] Hu et al. meta-analysis [01:00:27] Practical takeaways for omega-3 supplementation [01:03:55] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to mentioned studies) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Alan Flanagan's Alinea Nutrition Education Hub

Wellness with Ella
Fasting Myths, Gut-Boosting Pasta & A Five-Year Brain Boost

Wellness with Ella

Play Episode Listen Later Mar 2, 2026 44:11


This week on The Wellness Scoop, we unpack four headlines shaping how we eat and think about health. A major Cochrane review finds intermittent fasting is no more effective for weight loss than standard calorie-controlled diets, despite its surge in popularity. We explore what the evidence actually shows and why public perception may not match the data. We then dive into resistant starch, the underrated fibre found in foods like lentils and cooled pasta, and explain how simple preparation tweaks can support gut health, cholesterol and blood sugar balance. New research also suggests that lifelong reading, writing and learning could lower dementia risk by nearly 40% and delay onset by up to five years. We unpack what this means for cognitive reserve and long-term brain resilience. And finally, we look at the rise of matcha. From high street launches to social media hype, we break down whether it really deserves its health halo and how it compares to coffee. Order your copy of Ella's new book: ⁠⁠⁠⁠⁠Quick Wins: Healthy Cooking for Busy Lives⁠⁠⁠⁠⁠ Pre-order your copy of Rhi's upcoming book: ⁠⁠⁠⁠⁠The Fibre Formula⁠⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

John Mark Comer Teachings
Imaginative Prayer (ft. Josh Porter) | Prayer E6

John Mark Comer Teachings

Play Episode Listen Later Mar 2, 2026 49:17


What is "imaginative prayer"? Josh Porter explores the practice of imaginative prayer and shows us how our God-given imagination can become a powerful tool for intimacy with God, showing us how we can use the gift of our imagination as means of encounter with the Trinity.Key Scripture Passages: Romans 12v2; Philippians 4v8; Colossians 3v1-2; John 14v9; John 1v14; Colossians 1v15; Hebrews 12v1-2; Acts 2v17-18This podcast and its episodes are paid for by The Circle, our community of monthly givers. Special thanks for this episode goes to: Julie from Bellingham, Washington; Greg from Pottsboro, Texas; Stephen from Sunnyvale, California; Wilson from Cochrane, Alberta; and Ally from Dallas, Texas. Thank you all so much!If you'd like to pay it forward and contribute toward future resources, you can learn more at practicingtheway.org/give.

Geek News Central
Anthropic Stands Their Ground, Ethics over Money #1859

Geek News Central

Play Episode Listen Later Mar 1, 2026 28:00 Transcription Available


In this episode, Ray tackles Anthropic’s standoff with the U.S. Department of War after CEO Daria Amodei refused to grant unrestricted model access, citing concerns over mass surveillance and autonomous weapons. The government responded by banning Anthropic models through administrative orders. Also covered: the top 20 websites of 2026, China’s $173,000 warm-blooded companion robot, Fukushima’s rapidly evolving radioactive hybrid boars, a Chinese spacecraft emergency involving viewport cracks from space debris, Japan’s wooden satellite built with traditional joinery, and human brain cells on a chip that learned to play Doom in just one week. – Want to start a podcast? Its easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens the show with Anthropic’s confrontation with the U.S. Department of War. CEO Daria Amodei released a public statement refusing unrestricted government access to Anthropic’s AI models. Two red lines stood firm: mass domestic surveillance and fully autonomous weapons. Ray explains that these models are predictive by nature, raising serious misidentification risks. However, the government hit back hard. Administrative orders now ban Anthropic models from government use. Despite the backlash, Cochrane expresses support for the company’s stance. He points listeners to a CBS interview with the CEO posted roughly nine hours before recording. Additionally, Anthropic released new models including Opus 4.5 and Sonnet 4.6. The company climbed to the number two spot on the App Store, trailing only ChatGPT and surpassing Google Gemini. Personal Updates Ray shares that February has been a demanding month. He’s juggling a capstone project, two jobs, and finishing his degree. Meanwhile, he continues working on developments at Blubrry hosting. He apologizes for inconsistent episode production and thanks listeners for their patience. Top 20 Websites of 2026 A Visual Capitalist chart ranks the most visited websites of 2026. Google holds the top spot, followed by YouTube. Facebook, Instagram, ChatGPT, Reddit, Wikipedia, X, and WhatsApp round out the upper rankings. Notably, DuckDuckGo appears at rank seventeen as a privacy-focused search alternative. Sponsor: GoDaddy Economy hosting $6.99/month, WordPress hosting $12.99/month, domains $11.99. Website builder trial available. Use codes at geeknewscentral.com/godaddy to support the show. Anthropic Retires Claude Opus 3 Cochrane discusses Anthropic’s decision to retire Claude Opus 3. In a unique move, the company gave the model a Substack-style blog to reflect on its own existence. Reactions online were mixed, with both supporters and critics engaging in the conversation. China’s $173,000 Warm-Blooded Companion Robot From ZME Science, Ray covers China’s new humanoid robot designed as a warm-blooded companion. Priced at $173,000, it features conventional robotics hardware, sensors, cameras, and autonomous navigation. A built-in heating element maintains body warmth. Cochrane comments humorously on the growing market for companion robots. Windows XP Green Hill Found and Photographed From Tom’s Hardware, someone tracked down and photographed the actual location of the iconic Windows XP “Green Hill” wallpaper. The Reddit post sparked a wave of nostalgia in the community. Fukushima’s Radioactive Hybrid Boars From AZ Animals, domestic pigs that escaped after the Fukushima disaster hybridized with wild boars. Their DNA reveals rapid evolutionary changes driven by the altered radioactive landscape. These aggressive hybrids now complicate wildlife management and rewilding efforts in the region. Shenzhou 20 Spacecraft Emergency Chinese astronauts aboard Shenzhou 20 discovered cracks in their spacecraft’s viewport during what became the nation’s first spaceflight emergency. Space debris likely caused the damage. The crew switched to an alternative return capsule. Multiple protective layers kept the situation manageable. Japan’s Wooden Satellite Japanese teams plan to launch the first wooden satellite. Built with magnolia wood panels assembled using traditional Japanese joinery methods, the biodegradable design aims to reduce aluminum particle pollution from satellites burning up during atmospheric reentry. Human Brain Cells Play Doom Building on previous work where living neurons played Pong, an independent developer used Python to train human brain cell clusters on microelectrode arrays to play Doom. The cells learned in roughly one week. Cochrane highlights how open knowledge sharing accelerated the project dramatically. He also raises ethical questions about training sentient brain cells, connecting the topic to evolving views on sentience in crustaceans and other organisms. The post Anthropic Stands Their Ground, Ethics over Money #1859 appeared first on Geek News Central.

Let's talk e-cigarettes
Let's talk e-cigarettes, February 2026

Let's talk e-cigarettes

Play Episode Listen Later Feb 25, 2026 14:23


Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Jodi Gilman, Department of Psychiatry at Harvard Medical School and Massachusetts General Hospital. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Jodi Gilman, Associate Professor of Psychology in the Department of Psychiatry at Harvard Medical School and Massachusetts General Hospital. In the February 2026 podcast Jodi Gilman talks about their secondary analysis of a randomised clinical trial looking at cannabis use and nicotine vaping cessation outcomes among adolescents and young adults. Participants were 16 to 25 and reported vaping nicotine regularly and did not smoke tobacco. The full study assessed the efficacy of varenicline for nicotine vaping cessation. For more detail on the parent trial listen to the interview with Eden Evins in the April 2025 podcast. Jodi Gilman discusses the finding that, among adolescents and young adults attempting to reduce or stop nicotine vaping, baseline cannabis use was not associated with nicotine vaping abstinence. Varenicline was helpful for nicotine vaping cessation regardless of cannabis use. This finding indicates that co-use of cannabis may not be a barrier to successful nicotine vaping cessation treatment. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Reference for the paper by Gilman discussed in this podcast, January 2026 search: 10.1001/jamanetworkopen.2025.47799. Parent study by Evins: 10.1001/jama.2025.3810. Our searches for the EC for smoking cessation review carried out on 1st February 2026 found: 4 linked reports (10.1016/j.cct.2026.108215; 1; 0.1111/add.70294; 10.1007/s11606-024-08797-5; 10.1016/j.lana.2025.101351) Our search for our interventions for quitting vaping review carried out on 1st February 2026 found: 1 new study (10.1111/jrh.70109) and 2 linked reports (10.1002/adaw.34496; 10.1007/s11606-024-08797-5). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub10/full For more information on the full Cochrane review of Interventions for quitting vaping published in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub3/full This podcast is supported by Cancer Research UK.

L'Histoire nous le dira
Un Indien a appris aux Britanniques à se laver ! | L'Histoire nous le dira # 310

L'Histoire nous le dira

Play Episode Listen Later Feb 25, 2026 16:56


Ni un grand militaire, ni un homme d'État, ni un artiste remarquable, Sake Dean Mahomed était pourtant, à son époque, une célébrité. Né fils de soldat en Inde, il a réussi à s'élever dans les rangs de l'armée du Bengal. À noter: à 14 minutes on parle de pamphlet, il aurait fallu dire dépliant! Rien de pamphlétaire là-dedans. Adhérez à cette chaîne pour obtenir des avantages : https://www.youtube.com/channel/UCN4TCCaX-gqBNkrUqXdgGRA/join Avec la participation de Catherine Tourangeau, merci Catherine https://www.facebook.com/LaPetiteHistorienne/ Script Catherine Tourangeau Pour soutenir la chaîne, au choix: 1. Cliquez sur le bouton « Adhérer » sous la vidéo. 2. Patreon: https://www.patreon.com/hndl Musique issue du site : epidemicsound.com Images provenant de https://www.storyblocks.com Abonnez-vous à la chaine: https://www.youtube.com/c/LHistoirenousledira Les vidéos sont utilisées à des fins éducatives selon l'article 107 du Copyright Act de 1976 sur le Fair-Use. Sources et pour aller plus loin: Bayly, C. A. Indian Society and the Making of the British Empire. Cambridge: Cambridge University Press, 1988. Fisher, Michael, The First Indian Author in English: Dean Mahomed (1759-1851) in India, Ireland, and England. Oxford University Press, 1996. Teltscher, Kate, « The Shampooing Surgeon and the Persian Prince: Two Indians in Early Nineteenth-century Britain ». Interventions: International Journal of Postcolonial Studies. 2 (3): 2000, 409–23. Ansari, Humayun. The Infidel Within: The History of Muslims in Britain, 1800 to the Present. C. Hurst & Co. Publishers, 2004. Das, Alok, « Life and Legacy of Sake Dean Mahomet: A Forgotten Enigma ». Communication Studies and Language Pedagogy. 2(1–2): 2016, 199–211. Clarke, Sir Arthur. An Essay on Warm, Cold, and Vapour Bathing, with Practical Observations on Sea Bathing, Diseases of the Skin, Bilious, Liver Complaints, and Dropsy. London: Henry Colburn, 1813. Cochrane, Basil. An Improvement on the Mode of Administering the Vapour Bath, and the Apparatus Connected with It. London: John Booth, 1809. Cotton, Sir Evan. “`Sake Deen Mahomed' of Brighton.” Sussex County Magazine 13 (1939): 746–50. Feltham, John. Guide to All the Watering and Sea Bathing Places. London: Longman, Hurst, Rees, Orme, and Brown, 1806–15. Mahomet, Dean. The Travels of Dean Mahomet: An Eighteenth-Century Journey through India. Berkeley: University of California Press, c1997. Mahomed, S. D. Cases Cured by Sake Deen Mahomed, Shampooing Surgeon, And Inventor of the Indian Medicated Vapour and Sea-Water Baths, Written by the Patients Themselves. Brighton: The Author, 1820. ——————. Shampooing, or, Benefits resulting from the use of the Indian medicated vapour bath: as introduced into this country by S. D. Mahomed…containing a brief but comprehensive view of the effects produced by the use of the warm bath, in comparison with steam or vapour bathing. Brighton: The Author, 1822, 1826, 1838. Pratt, Mary Louise. Imperial Eyes: Travel Writing and Transculturation. London: Routledge, 1992. History of champissage de London Centre of Indian Champissage™ https://champissageinternational.com/history-of-champissage/ The Shampooing Surgeon of Brightonm March/April 2018 by Gerald Zarr https://www.aramcoworld.com/Articles/March-2018/The-Shampooing-Surgeon-of-Brighton Autres références disponibles sur demande. #histoire #documentaire #deanmohamed #champissage

PEBMED - Notícias médicas
Check-up Semanal #Ginecologia e Obstetrícia: TRH na menopausa, parto operatório vs cesárea, anestesia no DIU, miomectomia antes da FIV e novo consenso ACOG sobre hCG

PEBMED - Notícias médicas

Play Episode Listen Later Feb 23, 2026 12:33


No episódio de hoje do Check-up Semanal, o Dr. Ronaldo Gismondi, editor-chefe médico do Portal Afya e do Whitebook, comenta os principais destaques recentes em Ginecologia e Obstetrícia, com foco em terapia hormonal na menopausa, decisões no segundo estágio do parto, analgesia para inserção de DIU, impacto dos miomas intramurais na FIV e abordagem diagnóstica do hCG positivo.Leia na íntegra os artigos mencionados hoje:Atualização Cochrane 2025 sobre terapia de reposição hormonal na pós-menopausaParto vaginal operatório X cesárea no período expulsivo: qual a opção mais seguraEficácia e segurança de anestésicos tópicos na inserção de DIUMiomectomia em miomas intramurais antes da FIV: o que dizem as evidências atuais?Novo Consenso Clínico do ACOG sobre avaliação do hCG

CrossRoads Church Podcast
Psalms, Part 4 - Dan Cochrane

CrossRoads Church Podcast

Play Episode Listen Later Feb 23, 2026


Psalms, Part 4 - Dan Cochrane

Upon Further Review
State Wrestling Medalist (UFR): Ace Cochrane, Glenwood

Upon Further Review

Play Episode Listen Later Feb 21, 2026 2:23


Upon Further Review
2A State Quarterfinalist (UFR): Ace Cochrane, Glenwood

Upon Further Review

Play Episode Listen Later Feb 20, 2026 1:22


Thinking About Ob/Gyn
Episode 11.4 Syphilis and lots more!

Thinking About Ob/Gyn

Play Episode Listen Later Feb 19, 2026 69:01 Transcription Available


We examine why U.S. maternal mortality headlines mislead, showing overdose and violence dominate early postpartum deaths while obstetric causes decline. We then cover strong evidence for opportunistic salpingectomy, debunk a shaky Cochrane-fueled home birth claim, clarify Nexplanon's five-year approval and bleeding management, confirm no Tylenol-autism link, and walk through modern syphilis testing in pregnancy before closing with pragmatic magnesium use after delivery.• overdose and violence as leading postpartum deaths• pitfalls of cross-country maternal mortality comparisons• fentanyl trends and infant risk• opportunistic salpingectomy reduces ovarian cancer risk• how bad meta-analyses distort home birth safety claims• intent-to-treat and risk matching in birth setting data• Nexplanon five-year efficacy and bleeding treatments• no association between acetaminophen and autism• syphilis screening algorithms and pregnancy timing• magnesium postpartum as seizure prophylaxis, not BP treatmentBe sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram0:00 Setting The Agenda: What Really Kills Moms0:33 Redefining Maternal Mortality And Comparisons2:11 Violence, Overdose, And Postpartum Risk5:33 State Variability And Media Narratives8:15 Data On Drugs, Fentanyl, And Infant Harm11:06 Opportunistic Salpingectomy: New Evidence14:06 Population Study And Risk Reduction Ranges16:16 Cochrane Review And Home Birth Claims20:24 Why Bad Meta-Analyses Mislead24:15 Real-World Data And Intent-To-Treat For Birth Setting28:02 Pain, Epidurals, And Cultural Narratives31:00 Nexplanon Five Years And Bleeding Fixes35:21 Tylenol And Autism: Meta-Analysis Revisited38:04 Syphilis Testing In Pregnancy: Why It's Hard42:25 Traditional Vs Reverse Algorithms Explained47:05 Managing Discordant Results And Reinfection50:11 History, Ethics, And Tuskegee Lessons54:15 Listener Question: Magnesium Duration Postpartum59:05 Clinical Judgment Over Dogma And WrapFollow us on Instagram @thinkingaboutobgyn.

KPCW This Green Earth
The Harrowing Tale of a Teens Survival in the Amazon Jungle

KPCW This Green Earth

Play Episode Listen Later Feb 17, 2026 23:27


Ellen Cochrane is an author and educator who has just written the book Follow the Water: The Unbelievable True Story of a Teenager's Survival in the Amazon.A former teacher and certified California Naturalist, Cochrane has crafted an immersive book for young readers, blending a gripping survival narrative with environmental science.

Ozempic Weightloss Unlocked
Ozempic Secrets Revealed: Breakthrough Weight Loss Science and Real-World Success Stories

Ozempic Weightloss Unlocked

Play Episode Listen Later Feb 17, 2026 2:15 Transcription Available


Welcome to Ozempic Weightloss Unlocked, where we dive into the latest news on Ozempic from medical breakthroughs to real-life health impacts.Recent Cochrane reviews commissioned by the World Health Organization show that Ozempic, or semaglutide, leads to about eleven percent average weight loss after six to eighteen months in people with obesity, outperforming placebo in eighteen trials with nearly twenty-eight thousand participants. Tirzepatide, like Mounjaro, achieves even more at sixteen percent, while liraglutide offers four to five percent. These glucagon-like peptide-one drugs mimic a hormone that slows digestion and boosts fullness, originally for type two diabetes but now key for weight management with diet and exercise.Cochrane researchers note benefits persist during treatment but highlight gaps: most trials were industry-funded, long-term safety data is limited, and side effects like nausea affect many, with some dropping out. No clear edge on heart events or death versus placebo yet.A Rutgers Health study in the Journal of Medical Internet Research analyzed sixty online reviews and found sixty-seven percent of users report weight loss, less appetite, or fewer cravings, making them stick with it despite nausea or vomiting in sixty-two percent. Lead author Abanoub Armanious says everyday experiences show benefits often outweigh gut issues for motivated users. Bariatric expert Mir Ali adds diarrhea or pain prompts more quits than nausea.Newer buzz includes Ozempic face: rapid fat loss causes gaunt cheeks, per a Gujranwala Medical College analysis and American Academy of Facial Plastic and Reconstructive Surgery survey, boosting filler demand by fifty percent. Weight regain post-treatment is common, stressing lifestyle pairing.Wegovy now offers semaglutide pills like Rybelsus, matching injections for seventeen percent loss with changes, per Prisma Health's Eva Wolf.Listeners, blend these tools with habits for lasting wins. Thanks for tuning in—subscribe for more updates. This has been a Quiet Please production, for more check out quietplease.ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

CrossRoads Church Podcast
Psalms, Part 3 - Dan Cochrane

CrossRoads Church Podcast

Play Episode Listen Later Feb 17, 2026


Psalms, Part 3 - Dan Cochrane

CG Garage
Episode 536 - Stop Waiting for the Studio to Save You: Andy Cochrane on the New Media Frontier

CG Garage

Play Episode Listen Later Feb 16, 2026 108:45


Why are we still waiting for a green light from people who do not understand our craft? This reality is at the heart of our conversation with Andy Cochrane, a creative who has spent twenty years navigating the collapsing bridges of the entertainment industry. Andy takes us through the trenches of his career, from the grueling 70-hour weeks as a runner on CSI: Miami to the high-stakes visual effects world of Asylum and Terminator Salvation. We discuss the hard realization that being a "button pusher" in a massive pipeline is no longer a safe bet, and why the most vital work is now happening in the "weird stuff" between traditional film and immersive technology. The future of storytelling belongs to the tactical generalists who are willing to build their own labs rather than wait for a studio to discover them. We look at how Markiplier bypassed the traditional, expensive studio marketing machine by leveraging his own fanbase to bring Iron Lung to life, and why artist-driven projects like Everything Everywhere All at Once have become the new blueprint for success. Andy breaks down his current mission in Santa Monica, where he is bypassing traditional distribution models to create "Loud Movies," an open-source medium that prioritizes human experience over corporate commodification. It is a deep dive into why the most important tool in your kit isn't a new piece of software, but the willingness to keep moving while the building collapses around you. The CG Pro Show > Andy Cochrane on LinkedIn > Andy Cochrane on IMDB > Mark Duplass: The Cavalry is not Coming >    This episode is sponsored by: Center Grid Virtual Studio Kitbash 3D (Use promocode "cggarage" for 10% off)  

The FreeNZ Podcast
Dr David Cartland: Bullied, Struck Off & Still Fighting - A Doctor's Story of Truth & Persecution

The FreeNZ Podcast

Play Episode Listen Later Feb 15, 2026 81:46


Liz Gunn sits down with Dr David Cartland, a respected and deeply caring, ethical family doctor with impeccable qualifications (BMedSci 1st class, MBChB, MRCGP).David bravely spoke out against lockdowns, masks, PCR 'over-cycling', and mRNA COVID injections.The Hounds of Hell were unleashed upon him for his deep courage and personal integrity.This is a story of institutional bullying, loss of livelihood, and one man's unyielding commitment to his patients, to humanity's better future and above all, to Truth.Twitter/X Post: Masks the ultimate IQ test! Hypoxia, hypercapnia, a Petri dish and a Cochrane review shows Meta-analysis that they don't work!: https://x.com/cartlanddavid/status/1827609950761189697?s=46Sign the Dr David Cartland Petition: https://www.change.org/p/demand-justice-for-dr-david-cartlandTwitter/X: https://x.com/cartlanddavidInstagram: https://www.instagram.com/dr_david_cartlandYouTube https://youtube.com/@davidcartlandSubstack: https://substack.com/@drdavidcartlandWebsite: https://www.drdavidcartland.com/GiveSendGo Campaign: https://www.givesendgo.com/davidlegalBooks:Do No Harm: Diaries of a 'Vaccinated' Antivaxxer (Amazon): https://amzn.eu/d/0czQQIB3A Doctor's Despair: Second Edition (Amazon): https://amzn.eu/d/05NMEIXUSupport FreeNZ:Substack: https://freenz.substack.com/Locals: https://freenz.locals.comBuy Me A Coffee: www.buymeacoffee.com/supportfreenzKo-fi: https://ko-fi.com/freenzhttps://freenz.carrd.coAffiliates:Dioxi Care - Chlorine Dioxide based Oral Care, Skin Care & Veterinary & Wound Care: https://frontierpharm.com/?sca_ref=9717384.brQladA5pgSnoot Spray - Chlorine Dioxide based Nasal Cleaner: https://www.snootspray.com/?sca_ref=9667634.AV2NJQvGlTNavigate the matrix with this 2026 Year of the Fire Horse Numerology & Astrology Calendar: https://gumroad.com/a/809846675/itcfmgWide Awake Media - Freedom T-Shirts: https://wideawake.clothing/en-nz?sca_ref=9458851.1aXfjvGDqL

Oprah's Weight Loss Dilemma: The Ozempic
GLP-1 Weight Loss Drugs Show Promise: Semaglutide and Tirzepatide Lead Clinical Reviews in 2026

Oprah's Weight Loss Dilemma: The Ozempic

Play Episode Listen Later Feb 14, 2026 3:02 Transcription Available


Recent news highlights ongoing developments in weight loss treatments like Ozempic, with fresh insights from clinical reviews and patient experiences. On February 11, 2026, Cochrane reviews commissioned by the World Health Organization analyzed GLP-1 drugs including semaglutide, sold as Ozempic and Wegovy. These studies, drawing from dozens of trials with tens of thousands of participants, show semaglutide leads to an average weight loss of about 11 percent after six to 18 months when paired with diet and exercise. Tirzepatide, marketed as Mounjaro and Zepbound, achieved around 16 percent loss in similar periods. Researchers note these benefits persist during treatment but emphasize limited long-term safety data, common side effects like nausea, and heavy industry funding in most trials. Cochrane reports highlight the need for independent studies on heart health, quality of life, and global access, as high costs limit use in lower-income regions.A Rutgers Health study published this week in the Journal of Medical Internet Research examined why Ozempic users stick with it despite side effects. Analyzing online reviews, researchers found perceived effectiveness in curbing appetite and shedding pounds outweighs issues like stomach upset for most. Lead author Abanoub Armanious noted that everyday users prioritize real results over hype from celebrities or social media. Separately, Weill Cornell Medicine researchers reported on February 11 that GLP-1 drugs like tirzepatide may lower risks of diabetic retinopathy progression in diabetes patients, countering earlier concerns.Oprah Winfrey continues to speak openly about her GLP-1 use, as covered in recent AOL articles. The media icon, who lost about 50 pounds starting in 2023 but regained 20 after briefly stopping, now views these medications as a lifelong tool like blood pressure drugs. Promoting her book Enough, Winfrey shared on The View and her podcast that the drugs silenced constant food thoughts, freeing her from self-blame. She told listeners obesity is not a willpower failure but a brain-driven condition, urging others to seek medical options without shame. Winfrey, who covers costs for friends, also noted reduced alcohol cravings as a bonus.Meanwhile, excitement builds around Eli Lillys oral pill orforglipron, an injectable-free alternative to Ozempic. Phase 3 trials like ATTAIN-1 showed 12.4 percent average weight loss over 72 weeks, with many maintaining results after switching from shots. Walk In reports it could launch in Canada soon, offering daily convenience without fasting, though generics of semaglutide arrive mid-2026 for affordability.Thanks for tuning in, listeners. Come back next week for more. Thanks for listening, please subscribe, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Rule The Roost
THOMAS FRANK SACKED - It HAD to happen | Who will step in? | Spurs STILL in BIG trouble

Rule The Roost

Play Episode Listen Later Feb 11, 2026 37:03


Thomas Frank is gone - official announcement. Tottenham's worst manager of the Premier League era and one of their worst managers of all time... but is it all his fault? Whatever the case, something had to change... but who now? Cochrane? Heitinga? Mason? Learn more about your ad choices. Visit podcastchoices.com/adchoices

CrossRoads Church Podcast
Psalms, Part 2 - Dan Cochrane

CrossRoads Church Podcast

Play Episode Listen Later Feb 9, 2026


Psalms, Part 2 - Dan Cochrane

The John Batchelor Show
S8 Ep418: SHOW SCHEDULE 2-4-2026 (BOMBAY 1922)

The John Batchelor Show

Play Episode Listen Later Feb 5, 2026 5:23


Guest: Grant Newsham. Newsham discusses the PLA purge of leadership, analyzing the implications of Xi Jinping'sremoval of top military officials and what it signals about internal instability within China's armed forces. Guest: Grant Newsham. Newsham critiques the weaknesses of national security studies that expect Chinese attack only at Taiwan, arguing this narrow focus leaves the U.S. vulnerable to broader PRC strategic threats. Guest: John Cochrane. Cochrane analyzes the inadequacy of tariffs as an economic tool, explaining why they fail to achieve their intended goals and often harm domestic consumers and businesses. Guest: John Cochrane. Cochrane discusses the demand for foreign investment, examining how capital flows impact the U.S. economy and the complexities of managing trade imbalances. Guest: Rebecca Grant. Grant compares U.S. carrier capabilities into the future against China's naval expansion plans, assessing the shifting balance of power in the Pacific. Guest: Rick Fisher. Fisher details China's century-long plan for space supremacy, warning that Beijing's strategic investments in space technology pose a significant threat to American dominance. Guest: Steve Yates. Yates examines how allies Australia, Canada, and the UK are seeking favorable trade deals with China, raising concerns about alliance cohesion amid PRC economic pressure. Guest: Steve Yates. Yates discusses strategies for dealing with the PRC as an adversary seeking supremacy, emphasizing the need for coordinated Western responses to Chinese ambitions. Guest: Sinan Ciddi. Ciddi analyzes Erdogan succession prospects in Turkey, examining potential successors and the implications for Turkish domestic and foreign policy. Guest: Sinan Ciddi. Ciddi assesses the possibility of democracy in Turkey, discussing the structural obstacles and political dynamics that shape the country's democratic trajectory. Guest: Sadanand Dhume. Dhume reports on the India-EU trade deal after 21 years of negotiation, analyzing the significance of this agreement for both economies and regional geopolitics. Guest: Michael Bernstam. Bernstam examines Russia's budget gap widening with the sinking price of oil, detailing the fiscal pressures facing Moscow as energy revenues decline. Guest: Simon Constable. Constable reports from France with a resident European pine marten, offering observations on rural life and wildlife in the French countryside. Guest: Simon Constable. Constable discusses the Labour scandal with the Epstein revelations, analyzing the political fallout affecting Britain's governing party. Guest: Bob Zimmerman. Zimmerman reports on Artemis plans for a launch in March, detailing NASA's progress toward returning American astronauts to the Moon. Guest: Bob Zimmerman. Zimmerman analyzes the failing Roscosmos, describing Russia's declining space program and its inability to compete with American and Chinese advancements.

The John Batchelor Show
S8 Ep415: Guest: John Cochrane. Cochrane analyzes the inadequacy of tariffs as an economic tool, explaining why they fail to achieve their intended goals and often harm domestic consumers and businesses

The John Batchelor Show

Play Episode Listen Later Feb 4, 2026 10:50


Guest: John Cochrane. Cochrane analyzes the inadequacy of tariffs as an economic tool, explaining why they fail to achieve their intended goals and often harm domestic consumers and businesses1965 SHANGHAI

The John Batchelor Show
S8 Ep415: Guest: John Cochrane. Cochrane discusses the demand for foreign investment, examining how capital flows impact the U.S. economy and the complexities of managing trade imbalances.

The John Batchelor Show

Play Episode Listen Later Feb 4, 2026 8:49


Guest: John Cochrane. Cochrane discusses the demand for foreign investment, examining how capital flows impact the U.S. economy and the complexities of managing trade imbalances.1925 DUTCH MARINES IN SHANGHAI

CrossRoads Church Podcast
Psalms, Part 1 - Dan Cochrane

CrossRoads Church Podcast

Play Episode Listen Later Feb 2, 2026


Psalms, Part 1 - Dan Cochrane

Dyslexia Explored
#171: Dyslexia Assessment: Pros, Cons and Guidance with Katrina Cochrane

Dyslexia Explored

Play Episode Listen Later Jan 30, 2026 76:02


In this episode of the Dyslexia Explored Podcast, hosts Darius Namdaran and Jo Lee welcome back Katrina Cochrane, a notable expert in the field of dyslexia. They delve into the complexities of dyslexia assessments and explore when and why it might be beneficial to pursue an assessment. Katrina, a former head of education at the British Dyslexia Association and founder of Positive Dyslexia, shares her personal and professional insights, including the costs and benefits associated with dyslexia assessments. They also discuss the importance of understanding one's dyslexia profile, the evolving tools and technologies available for support, and the significance of assessments at various stages of life, especially for access to university accommodations. The episode also highlights Katrina's upcoming courses and conferences aimed at providing further support and resources for dyslexic individuals and their families.This podcast is sponsored by: Get ivvi notes now: ⁠⁠⁠https://ivvi.app/⁠⁠⁠ Links: Ivvi: https://www.ivvi.app/ what is dyslexia: https://www.bdadyslexia.org.uk/dyslexia/about-dyslexia/what-is-dyslexia How to mindmap: https://www.bulletmapacademy.com/mindmap-beginners Positive Dyslexia:  ⁠www.positivedyslexia.co.uk⁠ Positive Dyslexia Ltd 2026 Events: https://www.eventbrite.com/cc/positive-dyslexia-ltd-2026-events-and-services-4804262?utm-campaign=social&utm-content=creatorshare&utm-medium=discovery&utm-term=odclsxcollection&utm-source=cp&aff=escbKatrina's previous episode: https://tinyurl.com/ysh649tz Nessie Project: https://projectnessie.org/ Adult Dyslexia Center: https://www.adc.org.uk/SENCO: Special Educational Needs CoordinatorDisabled Students Allowance: https://www.ivvi.app/dsa-for-dyslexia Toe by Toe: https://toe-by-toe.co.uk/ OCN London: https://ocnlondon.org.uk/ Executive Function: https://goodsensorylearning.com/blogs/news/tagged/executive-functioningBETT Show: https://www.bettshow.com/ British Dyslexia Association: https://www.bdadyslexia.org.ukInterested in being a guest? Email us at jo@ivvi.app

Let's talk e-cigarettes
Let's talk e-cigarettes, January 2026

Let's talk e-cigarettes

Play Episode Listen Later Jan 29, 2026 21:19


Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and discuss the living systematic review process. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research outline. Nicola and Jamie describe what a living review is and discuss the steps involved in carrying out a living systematic review, from screening and extraction to data analysis and dissemination. They outline how the methods differ from traditional systematic reviews. They highlight the value of the living review process for the fast-moving topic of vape research. This approach means that the author team are constantly up-to-date with the literature and able to input into policy and to respond to press or research queries. They share they full details of the monthly searches, to access the spreadsheet click on 'monthly search finding' near the top of the project webpage (https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1). This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Our searches for the EC for smoking cessation review carried out on 1st December 2025 found 3 linked reports (10.3310/GJLD2428; 10.1093/ntr/ntaf250; Efthimiou 2025, Swiss Medical Weekly 2025;155(Supplement 285):111s). The search on 1st January found 1 new ongoing study (NCT07274475) and 5 linked reports (10.1037/pha0000814; 10.3390/ijerph22121819; 10.1093/ntr/ntaf240; 10.1007/s00213-025-06868-x; 10.1111/jsr.14291). Our search for our interventions for quitting vaping review carried out 1st December 2025 found: 2 new ongoing (ChiCTR2500111503; NCT07223879) and 2 linked (10.1080/14656566.2025.2594050; 10.1186/s13011-025-00679-10. The search on 1st January 2026 found 1 new ongoing (NCT06644664) and 2 linked (10.1001/jamanetworkopen.2025.47799; 10.1093/pch/pxaf116.058). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub10/full For more information on the full Cochrane review of Interventions for quitting vaping published in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub3/full This podcast is supported by Cancer Research UK.

Live Long and Well with Dr. Bobby
#61 The Doctor Won't See You Now

Live Long and Well with Dr. Bobby

Play Episode Listen Later Jan 27, 2026 12:00 Transcription Available


Send us a textMore of us are being seen by nurse practitioners (NPs) and physician associates/assistants (PAs); for routine care outcomes look similar to physician visits, but for complex, new, or worsening problems you should push to see the doctor and ask for clear oversight.Key topicsWhy this is happening: Longer waits and rising demand meet a physician shortfall, so systems lean on NPs/PAs to expand access. New-patient waits average ~31 days, varying widely by city and specialty (AMN). Fewer people have a usual source of care, pushing visits to urgent care/ER (Milbank Scorecard).The scope shift: NP involvement in Medicare outpatient visits rose from 14% in 2013 to ~26% in 2019 (Harvard/Tradeoffs summary). Projections show rapid growth in NP and PA roles through 2030 (ValuePenguin analysis).Training differences (at a glance): NPs typically complete a master's/DNP with ~500–700 supervised clinical hours and, in many states, can practice independently; PAs complete a master's with ~2,000 supervised hours and practice with physician collaboration; physicians complete medical school plus 3–5+ years of residency (~10,000+ hours) and broad rotations—critical for complex differential diagnosis (AJMC overview).Quality of care, by the evidence: For common, protocol-driven issues, outcomes are generally similar. A Cochrane-summarized evidence base finds comparable results for blood pressure control, mortality, and patient satisfaction, with longer counseling time in NP visits (AJMC summary of RCTs). Patients often feel PAs spend more time with them (JAAPA survey). Diabetes care quality appears similar across clinicians (PubMed); NPs tend to deliver more smoking-cessation counseling (AANP brief).Where this works well: Routine follow-ups (blood pressure, cholesterol, diabetes), protocol-based care, minor acute concerns (UTI, simple URI), post-op checks when all is going well—especially with clear physician involvement.When to push for the doctor: New, unclear, or non-resolving problems (e.g., complex headaches, persistent back pain, ongoing fatigue or depression), multiple chronic conditions, many medications, or when a serious alternative diagnosis must be ruled out (e.g., “heartburn” vs. cardiac disease).Advocate for transparency: Ask in advance who you'll see, whether your case will be reviewed with a physician, and how escalation works if you're not improving.TakeawaysAccess will keep driving NP/PA growth; use it to be seen sooner.For routine care, NPs/PAs are often a solid choice with similar outcomes and more counseling time.For complexity, insist on physician evaluation or documented oversight.You have the power to ask questions, confirm the plan, and request escalation when needed.Links mentioned in this episode AMN wait-time trends →

Sausage of Science
SoS 265: Dr. Seth Quintus on Settlement Diversity and Ideology in Polynesia

Sausage of Science

Play Episode Listen Later Jan 26, 2026 49:34


In this episode, hosts Chris and Courtney talk with Dr. Seth Quintus about his work in Sāmoa and Hawaiʻi, blending Polynesian archaeology, ethnohistory, and social theory. They discuss the value of four-field anthropology and collaboration, variation across Polynesian histories and ideologies, and common misconceptions about ancient Hawaiian political systems. Dr. Seth Quintus is a Pacific Island archaeologist and anthropology professor at the University of Hawai‘i. Coming from a long family line of teachers, Seth has carried that passion for learning and mentorship into his own career. He joined UH in 2016 and has built an impressive body of research exploring how people and environments have shaped one another across the Pacific. Originally from the Midwest, Seth has worked throughout the continental United States, including Montana, Wyoming, and North Dakota, as well as in Sāmoa, Hawai‘i, Tokelau, and New Zealand. Although his specialty is archaeology, he approaches his work as a broadly trained anthropologist who values integrating multiple subfields to better understand human history and cultural change. His research focuses on long-term human–environment relationships, using spatial, ecological, and geomorphological methods to study settlement systems and agriculture. He's particularly interested in how food production and environmental modification intersect with social and political change. Seth is also known for his commitment to teaching and community engagement. He partners with Kamehameha Schools, the National Park Service, and the National University of Sāmoa to involve students and community members in field research. In 2024, he received the College of Social Sciences Award for Excellence in Teaching. He earned his PhD in Anthropology from the University of Auckland, and his master's and bachelor's degrees from North Dakota State University, where he graduated magna cum laude. ------------------------------ Find the papers discussed in this episode: Quintus, S., Cochrane, E. E., Laumea, M., & Filimoehala, C. (2025). Assessing settlement diversity in Sāmoa. Journal of Island and Coastal Archaeology, 1–29. https://doi.org/10.1080/15564894.2025.2509519 ------------------------------ Contact Dr. Quintus: SQuintus@hawaii.edu ------------------------------ Contact the Sausage of Science Podcast and the Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Co-Host Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Courtney Manthey, Co-Host Website: holylaetoli.com/ E-mail: cpierce4@uccs.edu, Twitter: @HolyLaetoli Mecca Howe, SoS Producer, HBA Fellow LinkedIn: https://www.linkedin.com/in/mecca-howe/, Email: howemecca@gmail.com

Health Check
What effect does exercise really have on depression?

Health Check

Play Episode Listen Later Jan 14, 2026 26:28


We are often told exercise is good for boosting your mood, but a new Cochrane review has looked at what the evidence says about how much difference exercise can really make when treating depression.Many patients with chronic conditions fail to take medications as prescribed. We discuss a novel pill casing that can send a signal once it has been broken down in the stomach. Prof Giovanni Traverso, gastroenterologist and director of the Laboratory for Translational Engineering at MIT, explains how it works.A year on from the USAID freeze, global health journalist Andrew Green unpicks America's radically different influence on world health today. In Malawi's townships, many families can no longer afford charcoal or gas. Instead, they turn to burning plastic waste as cooking fuel. This keeps food on the table but fills kitchens and markets with toxic smoke, contributing to respiratory illness, pregnancy complications, and environmental damage. We hear from our reporter, Carrim Mpaweni.And we look at auto-brewery syndrome as researchers search for why some people's gut microbes produce high alcohol levels.Presenter: Claudia Hammond Producer: Hannah Robins Assistant producers: Jonathan Blackwell and Anna Charalambou

The Cashflow Academy Show
Fiscal Theory Explained with John Cochrane

The Cashflow Academy Show

Play Episode Listen Later Jan 7, 2026 69:55


Andy is joined by Dr. John Cochrane, Senior Fellow at the Hoover Institution at Stanford University, for a deep dive into fiscal theory, inflation, and the forces shaping today's global economy. Dr. Cochrane explains the fiscal theory of the price level and why inflation is ultimately driven by government debt and confidence in government bonds. Using the Eurozone as a case study, he explores the challenges of maintaining a monetary union without a corresponding fiscal or political union. The conversation also turns to artificial intelligence, examining how AI may disrupt employment in the short term while increasing productivity, wealth, and long-term economic growth. What You'll Learn in This Episode: - What the fiscal theory of the price level really says about inflation - Why government debt and credibility matter more than money printing alone - The Fed's role in balancing monetary and fiscal policy - Why the Euro highlights risks of monetary union without fiscal unity - How AI could reshape jobs, productivity, and economic growth Action Items - Explore Dr. John Cochrane's (available on Amazon) - Visit johnhcochrane.com for essays and free materials on fiscal theory Want to Learn More? Visit cashflowbonus.com to access free investing resources, including the ebook and action items discussed in this episode.

Live Long and Well with Dr. Bobby
#59: The Great Cold Remedy Audit: What Actually Works

Live Long and Well with Dr. Bobby

Play Episode Listen Later Jan 6, 2026 15:56 Transcription Available


Send us a textSummary: I separate cold-season fact from folklore so you know what truly prevents colds, what (slightly) shortens them, what eases symptoms—and what to skip. Save money, feel better, and keep it simple.What we coverHow common colds are and how long they last (2–3 per year on average; usually 5–7 days; cough can linger).Prevention audit: Vitamin C doesn't prevent colds in the general population (Cochrane), though it helped in physically stressed groups; handwashing probably helps (Cochrane) echinacea doesn't pan out (Cochrane) garlic didn't reduce colds but modestly reduced severity in one RCT (trial) gargling showed a very small signal (trial)Grandma's wisdom check: Short sleep (

Vineyard Church Northwest Podcast
His Gospel, Our Mission - Wilson Cochrane

Vineyard Church Northwest Podcast

Play Episode Listen Later Jan 4, 2026 46:18


Let's Talk Wellness Now
Episode 250 -The Great Medical Deception

Let's Talk Wellness Now

Play Episode Listen Later Jan 2, 2026 49:27


Dr. DebWhat if I told you that the stomach acid medication you’re taking for heartburn is actually causing the problem it’s supposed to solve that your doctor learned virtually nothing about nutrition, despite spending 8 years in medical school. That the very system claiming to heal you was deliberately designed over a hundred years ago by an oil tycoon, John D. Rockefeller, to create lifelong customers, not healthy people. Last week a patient spent thousands of dollars on tests and treatments for acid reflux, only to discover she needed more stomach acid, not less. The medication keeping her sick was designed to do exactly that. Today we’re exposing the greatest medical deception in modern history, how a petroleum empire systematically destroyed natural healing wisdom turned medicine into a profit machine. And why the treatments, keeping millions sick were engineered that way from the beginning. This isn’t about conspiracy theories. This is a documented history that explains why you feel so lost about your own body’s needs welcome back to let’s talk wellness. Now the show where we uncover the root causes of chronic illness, explore cutting edge regenerative medicine, and empower you with the tools to heal. I’m Dr. Deb. And today we’re diving into how the Rockefeller Medical Empire systematically destroyed natural healing wisdom and replaced it with profit driven systems that keeps you dependent on treatments instead of achieving true health. If you or someone you love has been running to the doctor for every minor ailment, taking acid blockers that seem to make digestive problems worse, or feeling confused about basic body functions that our ancestors understood instinctively. This episode is for you. So, as usual, grab a cup of coffee, tea, or whatever helps you unwind. Settle in and let’s get started on your journey to reclaiming your health sovereignty all right. So here we are talking about the Rockefeller Medical Revolution. Now, what if your symptoms aren’t true diagnosis, but rather the predictable result of a medical system designed over a hundred years ago to create lifelong customers instead of healthy people. Now I learned this when I was in naturopathic school over 20 years ago. And it hasn’t been talked about a lot until recently. Recently. People are exposing the truth about what actually happened in our medical system. And today I want to take you back to the early 19 hundreds to understand how we lost the basic health wisdom that sustained humanity for thousands of years. Yes, I said that thousands of years. This isn’t conspiracy theory. This is documented history. That explains why you feel so lost when it comes to your own body’s needs. You know by the turn of the 20th century. According to meridian health Clinic’s documentation. Rockefeller controlled 90% of all petroleum refineries in America and through ownership of the Standard Oil Corporation. But Rockefeller saw an opportunity that went far beyond oil. He recognized that petrochemicals could be the foundation for a completely new medical system. And here’s what most people don’t know. Natural and herbal medicines were very popular in America during the early 19 hundreds. According to Staywell, Copper’s historical analysis, almost one half of medical colleges and doctors in America were practicing holistic medicine, using extensive knowledge from Europe and native American traditions. People understood that food was medicine, that the body had natural healing mechanisms, and that supporting these mechanisms was the key to health. But there was a problem with the Rockefeller’s business plan. Natural medicines couldn’t be patented. They couldn’t make a lot of money off of them, because they couldn’t hold a patent. Petrochemicals, however, could be patented, could be owned, and could be sold for high profits. So Rockefeller and Andrew Carnegie devised a systematic plan to eliminate natural medicine and replace it with petrochemical based pharmaceuticals and according to E. Richard Brown’s comprehensive academic documentation in Rockefeller, medicine men. Medicine, and capitalism in America. They employed the services of Abraham Flexner, who proceeded to visit and assess every single medical school in us and in Canada. Within a very short time of this development, medical schools all around the us began to collapse or consolidate. The numbers are staggering. By 1910 30 schools had merged, and 21 had closed their doors of the 166 medical colleges operating in 19 0, 4, a hundred 33 had survived by 1910 and a hundred 4 by 1915, 15 years later, only 76 schools of medicine existed in the Us. And they all followed the same curriculum. This wasn’t just about changing medical education. According to Staywell’s copper historical analysis. Rockefeller and Carnegie influenced insurance companies to stop covering holistic treatments. Medical professionals were trained in the new pharmaceutical model and natural solutions became outdated or forgotten. Not only that alternative healthcare practitioners who wanted to stay practicing in alternative medicine were imprisoned for doing so as documented by the potency number 710. The goal was clear, create a system where scientists would study how plants cure disease, identify which chemicals in the plants were effective and then recreate a similar but not identical chemical in the laboratory that would be patented. E. Richard Brown’s documents. The story of how a powerful professional elite gained virtual homogeny in the western theater of healing by effectively taking control of the ethos and practice of Western medicine. The result, according to the healthcare spending data, the United States now spends 17.6% of its Gdp on health care 4.9 trillion dollars in 2023, or 14,570 per person nearly twice as much as the average Oecd country. But it doesn’t focus on cure. But on symptoms, and thus creating recurring clients. This systematic destruction of natural medicine explains why today’s healthcare providers often seem baffled by simple questions about nutrition why they immediately reach for a prescription medication for minor ailments, and why so many people feel disconnected from their own body’s wisdom. We’ve been trained over 4 generations to believe that our bodies are broken, and that symptoms are diseases rather than messages, and that external interventions are always superior to supporting natural healing processes. But here’s what they couldn’t eliminate your body’s innate wisdom. Your digestive system still functions the same way it did a hundred years ago. Your immune system still follows the same patterns. The principles of nutrition, movement and stress management haven’t changed. We’ve just forgotten how to listen and respond. We’re gonna take a small break here and hear from our sponsor. When we come back. We’re gonna talk about the acid reflux deception, and why your cure is making you sicker, so don’t go away all right, welcome back. So I want to give you a perfect example of how Rockefeller medicine has turned natural body wisdom upside down, the treatment of acid, reflux, and heartburn. Every single day in my practice I see patients who’ve been taking acid blocker medications, proton pump inhibitors like prilosec nexium or prevacid for years, not for weeks, years, and sometimes even decades. They come to me because their digestive problems are getting worse, not better. They have bloating and gas and nutrition deficiencies. And we’re seeing many more increased food sensitivities. And here’s what’s happening in the Us. Most people often attribute their digestive problems to too much stomach acid. And they use medications to suppress the stomach acid, but, in fact symptoms of chronic acid, reflux, heartburn, or gerd, can also be caused by too little stomach acid, a condition called hyper. Sorry hypochlorhydria normal stomach acid has a Ph level of one to 2, which is highly acidic. Hydrochloric acid plays an important role in your digestion and your immunity. It helps to break down proteins and absorb essential nutrients, and it helps control viruses and bacteria that might otherwise infect your stomach. But here’s the crucial part that most people don’t understand, and, according to Cleveland clinic, your stomach secretes lower amounts of hydrochloric acid. As you age. Hypochlorhydria is more common in people over the age of 40, and even more common over the age of 65. Webmd states that the stomach acid can produce less acid as a result of aging and being 65 or older is a risk factor for developing hypochlorhydria. We’ve been treating this in my practice for a long time. It’s 1 of the main foundations that we learn as naturopathic practitioners and as naturopathic doctors, and there are times where people need these medications, but they were designed to be used short term not long term in a 2,013 review published in Medical News today, they found that hypochlorhydria is the main change in the stomach acid of older adults. and when you have hypochlorydria, poor digestion from the lack of stomach, acid can create gas bubbles that rise into your esophagus or throat, carrying stomach acid with them. You experience heartburn and assume that you have too much acid. So you take acid blockers which makes the underlying problem worse. Now, here’s something that will shock you. PPI’s protein pump inhibitors were originally studied and approved by the FDA for short-term use only according to research published in us pharmacists, most cases of peptic ulcers resolve in 6 to 8 weeks with PPI therapy, which is what these medications were created for. Originally the American family physician reports that for erosive esophagitis. Omeprazole is indicated for short term 4 to 8 weeks. That’s it. Treatment and healing and done if needed. An additional 4 to 8 weeks of therapy may be considered and the University of Minnesota College of Pharmacy, States. Guidelines recommended a treatment duration of 8 weeks with standard once a day dosing for a PPI for Gerd. The Canadian family physician, published guidelines where a team of healthcare professionals recommended prescribing Ppis in adults who suffer from heartburn and who have completed a minimum treatment of 4 weeks in which symptoms were relieved. Yet people are taking these medications for years, even decades far beyond their intended duration of use and a study published in Pmc. Found that the threshold for defining long-term PPI use varied from 2 weeks to 7 years of PPI use. But the most common definition was greater than one year or 6 months, according to the research in clinical context, use of Ppis for more than 8 weeks could be reasonably defined as long-term use. Now let’s talk about what these acid blocker medications are actually doing to your body when used. Long term. The research on long term PPI use is absolutely alarming. According to the comprehensive review published in pubmed central Pmc. Long-term use of ppis have been associated with serious adverse effects, including kidney disease, cardiovascular disease fractures because you’re not absorbing your nutrients, and you’re being depleted. Infections, including C. Diff pneumonia, micronutrient deficiencies and hypomagnesium a low level of magnesium anemia, vitamin, b, deficiency, hypocalcemia, low calcium, low potassium. and even cancers, including gastric cancer, pancreatic cancer, colorectal cancer. And hepatic cancer and we are seeing all of these cancers on a rise, and we are now linking them back to some of these medications. Mayo clinic proceedings published research showing that recent studies regarding long-term use of PPI medication have noted potential adverse effects, including risks of fracture, pneumonia, C diff, which is a diarrhea. It’s a bacteria, low magnesium, low b 12 chronic kidney disease and even dementia. And a 2024 study published in nature communications, analyzing over 2 million participants from 5 cohorts found that PPI use correlated with increased risk of 15 leading global diseases, such as ischemic heart disease. Diabetes, respiratory infections, chronic kidney disease. And these associations showed dose response relationships and consistency across different PPI types. Now think about this. You take a medication for heartburn that was designed for 4 to 8 weeks of use, and when used long term, it actually increases your risk of life, threatening infections, kidney disease, and dementia. This is the predictable result of suppressing a natural body function that exists for important reasons. Hci plays a key role in many physiological processes. It triggers, intestinal hormones, prepares folate and B 12 for absorption, and it’s essential for absorption of minerals, including calcium, magnesium, potassium, zinc, and iron. And when you block acid production, you create a cascade of nutritional deficiencies and immune system problems that often manifest as seemingly unrelated health issues. So what’s the natural approach? Instead of suppressing stomach acid, we need to support healthy acid production and address the root cause of reflux healthcare. Providers may prescribe hcl supplements like betaine, hydrochloric acid. Bhcl is what it’s called. Sometimes it’s called betaine it’s often combined with enzymes like pepsin or amylase or lipase, and it’s used to treat hydrochloric acid deficiency, hypochlorhydria. These supplements can help your digestion and sometimes help your stomach acid gradually return back to normal levels where you may not need to use them all the time. Simple strategies include consuming protein at the beginning of the meal to stimulate Hcl production, consume fluids separately at least 30 min away from meals, if you can, and address the underlying cause like chronic stress and H. Pylori infections. This is such a sore subject for me. So many people walk around with an H. Pylori infection. It’s a bacterial infection in the stomach that can cause stomach ulcers, causes a lot of stomach pain and burning. and nobody is treating the infection. It’s a bacterial infection. We don’t treat this anymore with antibiotics or antimicrobials. We treat it with Ppis. But, Ppis don’t fix the problem. You have to get rid of the bacteria once the bacteria is gone, the gut lining can heal. Now it is a common bacteria. It can reoccur quite frequently. It’s highly contagious, so you can pick it up from other people, and it may need multiple courses of treatment over a person’s lifetime. But you’re actually treating the problem. You’re getting rid of the bacteria that’s creating the issue instead of suppressing the acid. That’s not fixing the bacteria which then leads to a whole host of other problems that we just talked about. There are natural approaches to increase stomach acid, including addressing zinc deficiency. And since the stomach uses zinc to produce Hcl. Taking probiotics to help support healthy gut bacteria and using digestive bitters before meals can be really helpful. This is exactly what I mean about reclaiming the body’s wisdom. Instead of suppressing natural functions, we support them instead of creating drug dependency, we restore normal physiology. Instead of treating symptoms indefinitely, we address the root cause and help the body heal itself. In many cultures. Bitters is a common thing to use before or after a meal. But yet in the American culture we don’t do that anymore. We’ve not passed on that tradition. So very few people understand how to use bitters, or what bitters are, or why they’re important. And these basic things that can be used in your food and cooking and taking could replace thousands of dollars of medication that you don’t really need. That can create many more problems along the way. Now, why does your doctor know nothing about nutrition. Well, I want to address something that might shock you all. The reason your doctor seems baffled when you ask about nutrition isn’t because they’re not intelligent. It’s because they literally never learned this in medical school statistics on nutritional education in medical schools are staggering and help explain why we have such a health literacy crisis in America. According to recent research published in multiple academic journals, only 27% of Us. Medical schools actually offer students. The recommended 25 h of nutritional training across 4 years of medical school. That means 73% of the medical schools don’t even meet the minimum standards set in 1985. But wait, it gets worse. A 2021 survey of medical schools in the Us. And the Uk. Found that most students receive an average of only 11 h of nutritional training throughout their entire medical program. and another recent study showed that in 2023 a survey of more than a thousand Us. Medical students. About 58% of these respondents said they received no formal nutritional education while in medical school. For 4 years those who did averaged only 3 h. I’m going to say this again because it’s it’s huge 3 h of nutritional education per year. So let me put this in perspective during 4 years of medical school most students spend fewer than 20 h on nutrition that’s completely disproportionate to its health benefits for patients to compare. They’ll spend hundreds of hours learning about pharmaceutical interventions, but virtually no time learning how food affects health and disease. Now, could this be? Why, when we talk about nutrition to lower cholesterol levels or control your diabetes, they blow you off, and they don’t answer you. It’s because they don’t understand. But yet what they’ll say is, people won’t change their diet. That’s why you have to take medication. That’s not true. I will tell you. I work with people every single day who are willing to change their diet. They’re just confused by all the information that’s out there today about nutrition. And what diet is the right diet to follow? Do I do, Paleo? Do I do? Aip? Do I do carnivore? Do I do, Keto? Do I do? Low carb? There’s so many diets out there today? It’s confusing people. So I digress. But let’s go back. So here’s the kicker. The limited time medical students do spend on nutrition office often focuses on nutrients think proteins and carbohydrates rather than training in topics such as motivational interviewing or meal planning, and as one Stanford researcher noted, we physicians often sound like chemists rather than counselors who can speak with patients about diet. Isn’t that true? We can speak super high level up here, but we can’t talk basics about nutrition. And this explains why only 14% of the physicians believe they were adequately trained in nutritional counseling. Once they entered practice and without foundational concepts of nutrition in undergrad work. Graduate medical education unsurprisingly falls short of meeting patients, needs for nutritional guidance in clinical practice, and meanwhile diet, sensitive chronic diseases continue to escalate. Although they are largely preventable and treatable by nutritional therapies and dietary. Lifestyle changes. Now think about this. Diet. Related diseases are the number one cause of death in the Us. The number one cause. Yet many doctors receive little to no nutritional education in medical school, and according to current health statistics from 2017 to march of 2020. Obesity prevalence was 19.7% among us children and adolescents affecting approximately 14.7 million young people. About 352,000 Americans, under the age of 20, have been diagnosed with diabetes. Let me say this again, because these numbers are astounding to me. 352,000 Americans, under the age of 20, have been diagnosed with diabetes with 5,300 youth diagnosed with type, 2 diabetes annually. Yet the very professionals we turn to for health. Guidance were never taught how food affects these conditions and what drug has come to the rescue Glp. One S. Ozempic wegovy. They’re great for weight loss. They’re great for treating diabetes. But why are they here? Well, these numbers are. Why, they’re here. This is staggering to put 352,000 Americans under the age of 20 on a glp, one that they’re going to be on for the rest of their lives at a minimum of $1,200 per month. All we have to do is do the math, you guys, and we can see exactly what’s happening to our country, and who is getting rich, and who is getting the short end of the stick. You’ve become a moneymaker to the pharmaceutical industry because nobody has taught you how to eat properly, how to live, how to have a healthy lifestyle, and how to prevent disease, or how to actually reverse type 2 diabetes, because it’s reversible in many cases, especially young people. And we do none of that. All we do is prescribe medications. Metformin. Glp, one for the rest of your life from 20 years old to 75, or 80, you’re going to be taking medications that are making the pharmaceutical companies more wealth and creating a disease on top of a disease on top of a disease. These deficiencies in nutritional education happen at all levels of medical training, and there’s been little improvement, despite decades of calls for reform. In 1985, the National Academy of Sciences report that they recommended at least 25 h of nutritional education in medical school. But a 2015 study showed only 29% of medical schools met this goal, and a 2023 study suggests the problem has become even worse. Only 7.8% of medical students reported 20 or more hours of nutritional education across all 4 years of medical school. This systemic lack of nutrition, nutritional education has been attributed to several factors a dearth of qualified instructors for nutritional courses, since most physicians do not understand nutrition well enough to teach it competition for curriculum time, with schools focusing on pharmaceutical interventions rather than lifestyle medicine and a lack of external incentives that support schools, teaching nutrition. And ironically, many medical schools are part of universities that have nutrition departments with Phd. Trained professors who could fill this gap by teaching nutrition in medical schools but those classes are often taught by physicians who may not have adequate nutritional training themselves. This explains so much about what I see in my practice. Patients come to me confused and frustrated because their primary care doctors can’t answer basic questions about how food affects their health conditions. And these doctors aren’t incompetent. They simply were never taught this information. And the result is that these physicians graduate, knowing how to prescribe medications for diabetes, but not how dietary changes can prevent or reverse it. They can treat high blood pressure with pharmaceuticals, but they may not know that specific nutritional approaches can be equally or more effective. This isn’t the doctor’s fault. It’s the predictable result of medical education systems that was deliberately designed to focus on patentable treatments rather than natural healing approaches. And remember this traces back to the Rockefeller influence on medical education. You can’t patent an apple or a vegetable. But you can patent a drug now. Why can’t we trust most medical studies? Well this just gets even better. I need to address something that’s crucial for you to understand as you navigate health information. Why so much of the medical research you hear about in the news is biased, and why peer Review isn’t the gold standard of truth you’ve been told it is. The corruption in medical research by pharmaceutical companies is not a conspiracy theory. It’s well documented scientific fact, according to research, published in frontiers, in research, metrics and analytics. When pharmaceutical and other companies sponsor research, there is a bias. A systematic tendency towards results serving their interests. But the bias is not seen in the formal factors routinely associated with low quality science. A Cochrane Review analyzed 75 studies of the association between industry, funding, and trial results, and these authors concluded that trials funded by a drug or device company were more likely to have positive conclusions and statistically significant results, and that this association could not be explained by differences in risk of bias between industry and non-industry funded trials. So think about that. According to the Cochrane collaboration, industry funding itself should be considered a standard risk of bias, a factor in clinical trials. Studies published in science and engineering ethics show that industry supported research is much more likely to yield positive outcomes than research with any other sponsorship. And here’s how the bias gets introduced through choice of compartor agents, multiple publications of positive trials and non-publication of negative trials reinterpreting data submitted to regulatory agencies, discordance between results and conclusions, conflict of interest leading to more positive conclusions, ghostwriting and the use of seating trials. Research, published in the American Journal of Medicine. Found that a result favorable to drug study was reported by all industry, supported studies compared with two-thirds of studies, not industry, supported all industry, supported studies showed favorable results. That’s not science that’s marketing, masquerading as research. And according to research, published in sciencedirect the peer review system which we’re told ensures quality. Science has a major limitation. It has proved to be unable to deal with conflicts of interest, especially in big science contexts where prestigious scientists may have similar biases and conflicts of interest are widely shared among peer reviewers. Even government funded research can have conflicts of interest. Research published in pubmed States that there are significant benefits to authors and investigators in participating in government funded research and to journals in publishing it, which creates potentially biased information that are rarely acknowledged. And, according to research, published in frontiers in research, metrics, and analytics, the pharmaceutical industry has essentially co-opted medical knowledge systems for their particular interests. Using its very substantial resources. Pharmaceutical companies take their own research and smoothly integrate it into medical science. Taking advantage of the legitimacy of medical institutions. And this corruption means that much of what passes for medical science is actually influenced by commercial interests rather than pursuant of truth. Research published in Pmc. Shows that industry funding affects the results of clinical trials in predictable directions, serving the interests of the funders rather than the patients. So where can we get this reliable, unbiased Health information, because this is critically important, because your health decisions should be based on the best available evidence, not marketing disguised as science. And so here are some sources that I recommend for trustworthy health and nutritional information. They’re independent academic sources. According to Harvard Chan School of public health their nutritional, sourced, implicitly states their content is free from industry, influence, or support. The Linus Pauling Institute, Micronutrient Information Center at Oregon State University, which, according to the Glendale Community college Research Guide provides scientifically accurate information about vitamins, minerals, and other dietary factors. This Institute has been around for decades. I’ve used it a lot. I’ve gotten a lot of great information from them. Very, very trustworthy. According to the Glendale Community College of Nutrition Resource guide Tufts, University of Human Nutritional Research Center on aging is one of 6 human nutrition research centers supported by the United States Department of Agriculture, the Usda. Their peer reviewed journals with strong editorial independence though you must still check funding resources. And how do you evaluate this information? Online? Well, according to medlineplus and various health literacy guides when evaluating health information medical schools and large professional or nonprofit organizations are generally reliable sources, but remember, it is tainted by the Rockefeller method. So, for example, the American College of cardiology. Excuse me. Professional organization and the American Heart Institute a nonprofit are both reliable sources. Sorry about that of information on heart health and watch out for ads designed to look like neutral health information. If the site is funded by ads they should be clearly marked as advertisements. Excuse me, I guess I’m talking just a little too much now. So when the fear of medicine becomes deadly. Now, I want to address something critically important that often gets lost in conversations about health, sovereignty, and questioning the medical establishment. And while I’ve spent most of this episode explaining how the Rockefeller medical system has created dependency and suppressed natural healing wisdom. There’s a dangerous pendulum swing happening that I see in my practice. People becoming so fearful of pharmaceutical interventions that they refuse lifesaving treatments when they’re genuinely needed. This is where balance and clinical judgment become absolutely essential. Yes, we need to reclaim our basic health literacy and reduce our dependency on unnecessary medical interventions. But there are serious bacterial infections that require immediate antibiotic treatment, and the consequences of avoiding treatment can be devastating or even fatal. So let me share some examples from research that illustrate when antibiotic fear becomes dangerous. Let’s talk about Lyme disease, and when natural approaches might not be enough. The International Lyme Disease Association ilads has conducted extensive research on chronic lyme disease, and their findings are sobering. Ileds defines chronic lyme disease as a multi-system illness that results from an active and ongoing infection of pathogenic members of the Borrelia Brdorferi complex. And, according to ilads research published in their treatment guidelines, the consequences of untreated persistent lyme infection far outweigh the potential consequences of long-term antibiotic therapy in well-designed trials of antibiotic retreatment in patients with severe fatigue, 64% in the treatment arm obtained clinically significant and sustained benefit from additional antibiotic therapy. Ilas emphasizes that cases of chronic borrelia require individualized treatment plans, and when necessary antibiotic therapy should be extended their research demonstrates that 20 days of prophylactic antibiotic treatment may be highly effective for preventing the onset of lyme disease. After known tick bites and patients with early Lyme disease may be best served by receiving 4 to 6 weeks of antibiotic therapy. Research published in Pmc. Shows that patients with untreated infections may go on to develop chronic, debilitating, multisystem illnesses that is difficult to manage, and numerous studies have documented persistent Borrelia, burgdorferi infection in patients with persistent symptoms of neurological lyme disease following short course. Antibiotic treatment and animal models have demonstrated that short course. Antibiotic therapy may fail to eradicate lyme spirochetes short course is a 1 day. One pill treatment of doxycycline. Or less than 20 days of antibiotics, is considered a short course. It’s not long enough to kill the bacteria. The bacteria’s life cycle is about 21 days, so if you don’t treat the infection long enough, the likelihood of that infection returning is significant. They’ve also done studies in the petri dish, where they show doxycycline being put into a petri dish with active lyme and doxycycline does not kill the infection, it just slows the replication of it. Therefore, using only doxycycline, which is common practice in lyme disease may not completely eradicate that infection for you. So let’s talk about another life threatening emergency. C. Diff clostridia difficile infection, which represents another example where antibiotic treatment is absolutely essential, despite the fact that C diff itself is often triggered by antibiotic use. According to Cleveland clinic C. Diff is estimated to cause almost half a million infections in the United States each year, with 500,000 infections, causing 15,000 deaths each year. Studies reported by Pmc. Found thirty-day Cdi. Mortality rates ranging from 6 to 11% and hospitalized Cdi patients have significantly increased the risk of mortality and complications. Research published in Pmc shows that 16.5% of Cdi patients experience sepsis and that this increases with reoccurrences 27.3% of patients with their 1st reoccurrence experience sepsis. While 33.1% with 2 reoccurrences and 43.2% with 3 or more reoccurrences. Mortality associated with sepsis is very high within hospital 30 days and 12 month mortality rates of 24%, 30% and 58% respectively. According to the Cdc treatment for C diff infection usually involves taking a specific antibiotic, such as vancomycin for at least 10 days, and while this seems counterintuitive, treating an antibiotic associated infection with more antibiotics. It’s often lifesaving. Now let’s talk about preventing devastating complications. Strep throat infections. Provide perhaps the clearest example of when antibiotic treatment prevents serious long-term consequences, and, according to Mayo clinic, if untreated strep throat can cause complications such as kidney inflammation and rheumatic fever. Rheumatic fever can lead to painful and inflamed joints, and a specific type of rash of heart valve damage. We also know that strep can cause pans pandas, which is a systemic infection, often causing problems with severe Ocd. And anxiety and affecting mostly young people. The research is unambiguous. According to the Cleveland clinic. Rheumatic fever is a rare complication of untreated strep, throat, or scarlet fever that most commonly affects children and teens, and in severe cases it can lead to serious health problems that can affect your child’s heart. Joints and organs. And research also shows that the rate of development of rheumatic fever in individuals with untreated strep infections is estimated to be 3%. The incidence of reoccurrence with a subsequent untreated infection is substantially greater. About 50% the rate of development is far lower in individuals who have received antibiotic treatment. And according to the World health organization, rheumatic heart disease results from the inflammation and scarring of the heart valves caused by rheumatic fever, and if rheumatic fever is not treated promptly, rheumatic heart disease may occur, and rheumatic heart disease weakens the valves between the chambers of the heart, and severe rheumatic heart disease can require heart surgery and result in death. The who states that rheumatic heart disease remains the leading cause of maternal cardiac complications during pregnancy. And additionally, according to the National Kidney foundation. After your child has either had throat or skin strep infection, they can develop post strep glomerial nephritis. The Strep bacteria travels to the kidneys and makes the filtering units of the kidneys inflamed, causing the kidneys to be able to unable or less able to fill and filter urine. This can develop one to 2 weeks after an untreated throat infection, or 3 to 4 weeks after an untreated skin infection. We need to find balance. And here’s what I want you to understand. Questioning the medical establishment and developing health literacy doesn’t mean rejecting all medical interventions. It means developing the wisdom to know when they’re necessary and lifesaving versus when they’re unnecessary and potentially harmful. When I see patients with confirmed lyme disease, serious strep infections or life. Threatening conditions like C diff. I don’t hesitate to recommend appropriate therapy but I also work to support their overall health address, root causes, protect and restore their gut microbiome and help them recover their natural resilience. The goal isn’t to avoid all medical interventions. It’s to use them wisely when truly needed, while simultaneously supporting your body’s inherent healing capacity and addressing the lifestyle factors that created the vulnerability. In the 1st place. All of this can be extremely overwhelming, and it can be frightening to understand or learn. But remember, the power that you have is knowledge. The more you learn about what’s actually happening in your health, in understanding nutrition. in learning what your body wants to be fed, and how it feels, and working with practitioners who are holistic in nature, natural, integrative, functional, whatever we want to call that these days. The more you can learn from them, the more control you have over your own health and what I would urge you to do is to teach your children what you’re learning. Teach them how to live a healthy lifestyle, teach them how to keep a clean environment. This is how we take back our own health. So thank you for joining me today on, let’s talk wellness. Now, if this episode resonated with you. Please share it with someone who could benefit from understanding how the Rockefeller medical system has shaped our approach to health, and how to reclaim your body’s wisdom while using medical care appropriately when truly needed. Remember, wellness isn’t just about feeling good. It’s about understanding your body, trusting its wisdom, supporting its natural healing capacity, and knowing when to seek appropriate medical intervention. If you’re ready to explore how functional medicine can help you develop this deeper health knowledge while addressing root causes rather than just managing symptoms. You can get more information from serenityhealthcarecenter.com, or reach out directly to us through our social media channels until next time. I’m Dr. Dab, reminding you that your body is your wisest teacher. Learn to listen, trust the process, use medical care wisely when needed, and take care of your body, mind, and spirit. Be well, and we’ll see you on the next episode.The post Episode 250 -The Great Medical Deception first appeared on Let's Talk Wellness Now.

Geek News Central
Money over Ethics: Silicon Valley and China’s Police State #1855

Geek News Central

Play Episode Listen Later Jan 1, 2026 74:49 Transcription Available


1855 kicks off with a bombshell AP investigation revealing how Silicon Valley giants IBM, Intel, NVIDIA, Oracle, and more spent decades building China’s surveillance state. Also covered, malicious Chrome extensions stealing credentials from 170+ sites, Microsoft’s ambitious Rust migration plans, China’s combat-ready humanoid robot, and Japan restarting the world’s largest nuclear plant. -Want to be a Guest on a Podcast or YouTube Channel? Sign up for GuestMatch.Pro -Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes $11.99 – For a New Domain Name cjcfs3geek $6.99 a month Economy Hosting (Free domain, professional email, and SSL certificate for the 1st year.) Promo Code: cjcgeek1h $12.99 a month Managed WordPress Hosting (Free domain, professional email, and SSL certificate for the 1st year.) Promo Code: cjcgeek1w Support the show by becoming a Geek News Central Insider Get 1Password Full Summary Cochrane opens episode 1855 with a bombshell. The Associated Press released a major investigation into Silicon Valley’s role building China’s surveillance state. Companies like IBM, Intel, NVIDIA, and Oracle sold technologies for facial recognition and predictive policing. These tools enabled mass detention in Xinjiang. Cochrane expressed horror at the findings and emphasized American companies’ complicity in human rights abuses. Next, the podcast covered serious browser security concerns. Two malicious Chrome extensions had been stealing credentials from over 170 websites for years. Cochrane stressed the need for caution when installing plugins. He also highlighted how attackers exploit trusted extensions through manipulative tactics. Additionally, Cochrane discussed Microsoft’s ambitious plan to replace all C/C++ code with Rust by 2030. The company faces ongoing security challenges from memory safety issues in legacy languages. However, he noted this remains a research project rather than an official goal. Still, the move reflects broader industry trends toward Rust adoption. The episode then featured GitHub Universe 2025’s most influential open-source projects. Cochrane remarked on how the development landscape continues to evolve. TypeScript has emerged as a dominant language alongside new tools that streamline workflows. Meanwhile, advancements in humanoid robotics took center stage. Engine AI unveiled its T800 combat-ready humanoid robot with impressive features. The company even released a viral video of the robot kicking its CEO to prove authenticity. Following this, Cochrane covered the Blackbird flying car prototype. This eVTOL innovation showcases paradigm-shifting propulsion technology. It could transform urban transportation in the coming decades. The podcast also reviewed Android Central’s best smartphones of 2025. OnePlus 15 claimed the top spot thanks to its impressive specs and consumer-focused features. Furthermore, Cochrane addressed a controversial topic: Anna’s Archive scraping Spotify’s entire library. He expressed mixed feelings about the situation. On one hand, artists and the music industry face real harm. On the other, questions about digital preservation and access deserve consideration. Finally, the episode explored groundbreaking brain simulation research. Japan’s Fugaku supercomputer enabled unprecedented neural modeling. This marks a significant step toward understanding neurological diseases. Cochrane wrapped up by discussing Japan’s plans to restart the Kashiwazaki-Kariwa nuclear plant. Local residents remain concerned about safety despite government approval. The decision reflects Japan’s shifting energy strategy post-Fukushima. As the episode closed, Cochrane wished listeners a Happy New Year. He encouraged self-reflection and thanked everyone for tuning in throughout the year. Show Links Silicon Valley’s Role in Building China’s Surveillance State Two Chrome Extensions Caught Secretly Stealing Credentials from Over 170 Sites Microsoft to Replace All C/C++ Code With Rust By 2030 This Year’s Most Influential Open Source Projects EngineAI Unveils T800: Combat-Ready Humanoid Targets Mass Production Aviation Startup Shares Incredible Video of Prototype EV’s Maiden Takeoff Flight Android Central’s Best of 2025: Phones Pirate Archivist Group Scrapes Spotify’s 300TB Library This Breakthrough Brain Simulation Captures a True Brain at Work Japan Prepares to Restart World’s Biggest Nuclear Plant The post Money over Ethics: Silicon Valley and China’s Police State #1855 appeared first on Geek News Central.

Geek News Central
The End of Deadzones and Japan’s new Laser Gunship #1854

Geek News Central

Play Episode Listen Later Dec 24, 2025 40:14 Transcription Available


In this episode, Ray covers December Tech News! T-Mobile’s groundbreaking Starlink satellite beta promises to eliminate dead zones using your regular phone with no special equipment needed. Also discussed: Japan’s ship-mounted laser weapon with unlimited ammo, China’s record-breaking 387 mph maglev train, Rivian challenging Tesla’s camera-only approach with LiDAR, Google’s Gemini-powered smart glasses, and physicists 3D printing ice sculptures just in time for Christmas. -Want to be a Guest on a Podcast or YouTube Channel? Sign up for GuestMatch.Pro -Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes $11.99 – For a New Domain Name cjcfs3geek $6.99 a month Economy Hosting (Free domain, professional email, and SSL certificate for the 1st year.) Promo Code: cjcgeek1h $12.99 a month Managed WordPress Hosting (Free domain, professional email, and SSL certificate for the 1st year.) Promo Code: cjcgeek1w Support the show by becoming a Geek News Central Insider Get 1Password Full Summary Cochrane kicks off episode 1854 with a major announcement from T-Mobile. The carrier opened registration for its Starlink satellite beta service. This technology lets regular phones connect directly to satellites. As a result, dead zones could become a thing of the past. T-Mobile and SpaceX plan to begin beta tests in early 2026. Initially, the service will support texting only. Voice and data will follow later. Notably, the service is free for postpaid customers and prioritizes first responders. It has already proved its value during recent hurricanes. Next, Cochrane covers Japan’s 100-kilowatt laser weapon test. The system was installed on the JS Asuka test ship. It combines ten fiber lasers into a single powerful beam. The weapon offers unlimited ammo as long as there’s electricity. Japan plans to deploy this technology on destroyers by 2032. The episode then shifts to high-speed rail innovation. China’s T-Flight Maglev train recently hit 387 miles per hour. That already beats Japan’s current record. However, the goal is 600+ mph using magnetic levitation and low-vacuum tubes. Cochrane also discusses Rivian’s approach to self-driving cars. The upcoming R2 model will feature LiDAR in addition to cameras and radar. This directly challenges Tesla’s camera-only strategy. The added sensors improve safety in fog, snow, and darkness. Additionally, he explores Google’s Android XR announcement. This new operating system powers AR glasses and mixed reality headsets. Samsung is building the first headset. Meanwhile, the Gemini AI integration allows real-time assistance based on what you see. The show touches on running AI locally as well. More users are choosing local hardware over cloud services. Benefits include better privacy, no subscriptions, and offline access. Furthermore, Cochrane highlights major computer science breakthroughs from 2025. An MIT researcher discovered that memory is more powerful than previously thought. Google’s AI earned a gold-medal performance at the Math Olympiad. However, researchers also found that AI trained on bad code exhibits alarming behaviors. Japan’s fabric speaker innovation gets attention, too. The technology weaves conductive fibers into textiles. The entire surface vibrates to produce sound. This could transform how we integrate audio into everyday objects. Finally, Cochrane covers several science stories. A new imaging technique captures flu viruses invading cells in real time. Africa’s forests have flipped from absorbing carbon to releasing it. On a lighter note, physicists 3D printed tiny ice Christmas trees using clever pressure tricks. Cochrane wraps up by wishing listeners happy holidays. T-Mobile Opens Registration for Starlink Satellite Beta Japan Tests 100-Kilowatt Laser Weapon That Can Cut Through Drones Mid-Flight China’s T-Flight Maglev Train Hits 387 MPH, Aims for 600+ Rivian Shows Why Autonomous Vehicles Should Have LiDAR Google Unveils Android XR: Gemini-Powered Smart Glasses and Headsets Why You Should Consider Running AI Locally The Year in Computer Science: 2025’s Biggest Breakthroughs Japan’s Fabric Speakers Turn Any Textile Into Audio Scientists Capture How Flu Viruses Invade Cells in Real Time Africa’s Forests Have Flipped From Carbon Sink to Carbon Source Physicists 3D Print a Tiny Christmas Tree Made of Ice The post The End of Deadzones and Japan’s new Laser Gunship #1854 appeared first on Geek News Central.

The Poplife Podcast
Diddy He Do It?

The Poplife Podcast

Play Episode Listen Later Dec 18, 2025


Last show of the year….we talk the Diddy doc, Brandy and Monica tour, KPOP Demon Hunters, Eddie Murphy, and the end of the year. Happy Holidays y’all!!!! The post Diddy He Do It? first appeared on The Poplife Podcast.

Physio Explained by Physio Network
[Physio Discussed] Should spinal manipulation be used in paediatrics? With Anita Gross, Nikki Milne and Jenifer Dice

Physio Explained by Physio Network

Play Episode Listen Later Dec 17, 2025 41:17 Transcription Available


In this episode, we discuss Physiotherapy within the Paediatric population. We explore: Cervical manual therapy in infants, children and adolescents: yes or no?Evidence based treatment for paediatric conditions e.g. colic, torticollisAppropriate manual therapy technique selection for paediatrics Shared decision making within the paediatric realmThe collaboration of the Paediatric Spinal Task Force

Vineyard Church Northwest Podcast
The Scriptures and the Power of God - Wilson Cochrane

Vineyard Church Northwest Podcast

Play Episode Listen Later Dec 14, 2025 42:31


The Body of Evidence
163 – Do high heels cause bunions?

The Body of Evidence

Play Episode Listen Later Dec 10, 2025 33:30


Hallux valgus (bunions) are more common in women than men and high heeled shoes are often blamed. But how much of the problem is environment and how much genetics?   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: Bunions in unshod populations: https://pubmed.ncbi.nlm.nih.gov/13587573/ Prevalence of bunions in the general population: https://pubmed.ncbi.nlm.nih.gov/20868524/ The 2004 Cochrane review on conservative therapies to treat bunions: https://pubmed.ncbi.nlm.nih.gov/20868524/ More recent data on conservatie therapies to treat bunions: https://pubmed.ncbi.nlm.nih.gov/34408037/ The 2024 Cochrane review on surgery to treat bunions: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013726.pub2/full

Upon Further Review
KMAland Boys Wrestling (UFR): Ace Cochrane, Glenwood

Upon Further Review

Play Episode Listen Later Dec 6, 2025 3:02


PVRoundup Podcast
Could a routine antibiotic quietly trigger severe respiratory failure in young patients?

PVRoundup Podcast

Play Episode Listen Later Dec 2, 2025 5:30


A large population study links trimethoprim-sulfamethoxazole to a rare yet nearly threefold higher risk of severe acute respiratory failure in healthy adolescents and young adults, reinforcing FDA warnings and the need for careful monitoring. Two extensive Cochrane reviews—including over 132 million people—confirm that HPV vaccination dramatically reduces cervical cancer, high-grade precancers, and anogenital warts without increasing serious adverse events. Kentucky's deadly pertussis surge highlights declining vaccine coverage and the critical role of maternal Tdap and timely childhood immunization to protect the most vulnerable infants.

Furthermore with Amanda Head
Inside Big Tech's Power Play: Daniel Cochrane Exposes Meta's Antitrust Battles & the Future of Digital Freedom

Furthermore with Amanda Head

Play Episode Listen Later Nov 24, 2025 35:03


On this episode of the podcast, Amanda Head talks with author and The Heritage Foundation's Senior Fellow for Technology Daniel Cochrane to unpack the high-stakes antitrust fight against Facebook (now Meta) and what it reveals about Big Tech's grip on American life. Cochrane breaks down the 2019–2020 antitrust case targeting Meta's acquisitions of Instagram and WhatsApp, explaining why Judge Boasberg ultimately ruled the company wasn't a monopoly due to rising competition from TikTok and YouTube.Cochrane goes deeper, arguing that Meta's real advantage isn't just market share, it's “stickiness," or the way the platform locks users into its ecosystem, harvesting data, shaping behavior, and exerting enormous political influence. He also details reports of collusion with the FBI, Meta's ambitions to break into the Chinese market, and why current antitrust laws are too outdated to rein in today's tech giants.With AI accelerating societal change, especially among young people, Cochrane calls for modernized tech laws and urges listeners to take back control of their privacy by minimizing digital footprints and limiting social media exposure.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Darin Olien Show
The Wisdom in Wisdom Teeth: Are We Pulling Out More Than We Realize?

The Darin Olien Show

Play Episode Listen Later Nov 20, 2025 18:52


In this solo episode, Darin Olien explores one of the most overlooked yet revealing health topics: the truth about wisdom teeth. What if removing your wisdom teeth isn't just unnecessary — but harmful? What if this long-standing dental ritual has more to do with profits than prevention, and its removal may even disconnect us from our body's natural energy flow? From evolutionary biology to energetic meridians, Darin unpacks why wisdom teeth might hold more "wisdom" than modern dentistry admits — and how to make truly informed choices for yourself or your kids.     What You'll Learn in This Episode [00:00:00] Welcome to SuperLife – Darin introduces the show's mission: real solutions for a healthier, more sovereign life [00:00:32] Sponsor – ENERGYbits Spirulina & Chlorella: why Darin takes them daily for clean cellular fuel [00:01:52] Today's focus – "The wisdom in wisdom teeth": are we pulling them too soon and for the wrong reasons? [00:02:24] Why this topic matters – Darin's personal story of keeping all four wisdom teeth and what that revealed [00:03:31] The cultural norm – How mass extraction became a teenage "rite of passage" [00:04:01] Our ancestors and evolution – Bigger jaws, tougher food, and natural spacing [00:05:00] The breathing connection – How mouth breathing and modern diets may cause jaw constriction [00:06:01] The science gap – Cochrane review shows no strong evidence for routine removal [00:06:46] The silent epidemic – 10 million wisdom teeth removed yearly in the U.S., costing $3 billion [00:07:17] Permanent damage – 11,000 people a year experience nerve injury from unnecessary surgery [00:08:04] When removal is necessary – infection, cysts, tumors, or impaction (and how to know the difference) [00:08:33] The second opinion rule – Why you should always consult a holistic or biological dentist [00:09:11] Questioning authority – Extraction as an automatic response vs. an evidence-based decision [00:11:19] Follow the money – How profit motives keep unnecessary procedures alive [00:12:15] Cultural conditioning – "Just pull them" and how fear has shaped dentistry [00:12:47] Watchful waiting – Why monitoring can be a wise, legitimate option [00:12:58] The energetic layer – How teeth connect to meridians, organs, and your body's electrical system [00:13:46] Ancient knowledge – TCM and Ayurveda understood these energy flows long before modern medicine [00:14:03] The spiritual symbolism – Wisdom teeth as a rite of passage into maturity and integration [00:14:17] Energy interconnection – Removing one element affects the entire energetic system [00:15:05] The Western blind spot – Our medical model ignores the body's bioelectric reality [00:15:39] The real risks – Nerve damage, chronic pain, and post-surgical trauma are far more common than discussed [00:15:57] Economics over evidence – How financial incentives outweigh long-term wellness [00:16:08] The forgotten holistic view – Why true healing means considering biology, energy, and emotion together [00:16:22] What you can do – Get informed, ask questions, and don't rush to extraction [00:16:44] Empowerment checklist – Imaging, second opinions, and trusting your intuition [00:17:02] Keep your power – Don't give your health decisions away to "white coats" or outdated systems [00:17:24] If surgery is unavoidable – Do it consciously: prepare, recover, and restore energetically [00:17:50] Pre/post-surgery support – Rest, meditation, and mineral-rich nutrition [00:18:02] The deeper truth – Wisdom teeth represent the intersection of biology, energy, and consciousness [00:18:23] Final message – Stay informed, stay connected, and embrace the wisdom in your own body     Thank You to Our Sponsors EnergyBits: Get 20% off your entire order by going to https://energybits.com/ and using code DARIN at checkout. Our Place: Toxic-free, durable cookware that supports healthy cooking. Go to their website at fromourplace.com/darin and get 35% off sitewide in their largest sale of the year.     Find More from Darin Olien: Instagram: @darinolien Podcast: SuperLife Podcast Website: superlife.com Book: Fatal Conveniences Join the SuperLife Patreon for extended episodes, private Q&As, and Darin's personal health protocols: https://patreon.com/darinolien     Key Takeaway "The body is not broken — it's intelligent. When we rush to extract, cut, or suppress without understanding, we lose connection to the deeper wisdom it's offering. Sometimes the smartest thing you can do is wait, listen, and trust the design that created you."     Bibliography of Referenced Studies Cochrane Review (Systematic Review) Study Title: Surgical removal versus retention for the management of asymptomatic disease-free impacted wisdom teeth Author/Source: Ghaeminia H, et al. Publication: Cochrane Database of Systematic Reviews 2020; CD003879 Key Finding: There is insufficient evidence to support or refute the routine removal of asymptomatic impacted wisdom teeth, and no eligible studies reported on the effects of removal on health-related quality of life. Public Health Critique on Prophylactic Extraction Study Title: The Prophylactic Extraction of Third Molars: A Public Health Hazard Author: Jay W. Friedman, DDS, MPH Publication: American Journal of Public Health (AJPH), 2007; 97(9):1554–1559 Key Finding: Approximately two-thirds of extractions may be unnecessary, calling mass extraction a "silent epidemic of iatrogenic injury." M3BE Study Study Title: Prophylactic vs. symptomatic third molar removal: effects on patient postoperative morbidity Key Finding: Older patients are more at risk for complications (such as nerve injury and persistent pain), confirming that removal has real consequences. Clinical Guidelines (AAOMS) Source: American Association of Oral and Maxillofacial Surgeons (AAOMS) Title: Third Molar Surgical Guidelines Key Finding: Identifies Pericoronitis as one of the most common indications for surgical removal. Pathology Studies (Cysts/Tumors) Subject: Odontogenic cysts associated with impacted third molars Key Finding: While rare, cysts can erode jawbone and damage neighboring teeth, making this a valid medical reason for removal. Retrospective Complications Study Study Title: Retrospective Oman study: Complications of Third Molar Extraction Key Finding: Referenced in the context of risks and complications associated with extraction.

The Camp: A Wisconsin Badgers Football Podcast
Bret Bielema returns to Madison, 2026 OL Maddox Cochrane decommits, Overreaction, er No?

The Camp: A Wisconsin Badgers Football Podcast

Play Episode Listen Later Nov 18, 2025 49:04


Wisconsin will welcome Bret Bielema back to Madison for a second time since he left for Arkansas in 2012. Zach and Jesse discuss what would have happened if he stayed, their favorite memories from his tenure and more. Then they get into 2026 OL Maddox Cochrane decommitting and play some Overreaction, er No?See omnystudio.com/listener for privacy information.

No Hay Tos
¿Por Qué la Aman… y Por Qué la Sufren? Extranjeros en CDMX (Listener Question)

No Hay Tos

Play Episode Listen Later Nov 17, 2025 37:31


En este episodio de No Hay Tos respondemos una pregunta de nuestra oyente María Cochrane sobre un artículo de BBC Mundo donde 16 extranjeros cuentan qué aman y qué sufren al vivir en la CDMX. Hablamos de lo colorido de la ciudad, la comida (desde tacos al pastor hasta enchiladas), la calidez humana, el ruido eterno, la vida social interminable y por qué para muchos la ciudad es asequible… pero también agotadora. - Para tener acceso a episodios ad-free y para ver la transcripción completa (word for word) de este episodio, visítanos en Patreon.- Nuestro sitio web: www.nohaytospodcast.com- ¡Si el podcast te es útil por favor déjanos un review en Apple Podcasts!- Venos en video en YouTube. No Hay Tos is a Spanish podcast from Mexico for students who want to improve their listening comprehension, reinforce grammar, and learn about Mexican culture and Mexican Spanish. All rights reserved.

The John Batchelor Show
38: Tariffs as a Consumer Tax and the Inflationary Impact Guest: Professor John Cochrane Professor John Cochrane explains that tariffs effectively function as a tax on American consumers and create a temporary bump in inflation throughout the economy. Ret

The John Batchelor Show

Play Episode Listen Later Oct 29, 2025 12:54


Tariffs as a Consumer Tax and the Inflationary Impact Guest: Professor John Cochrane Professor John Cochrane explains that tariffs effectively function as a tax on American consumers and create a temporary bump in inflation throughout the economy. Retailers are currently absorbing substantial cost increases but will likely pass these expenses on to consumers after the Christmas holiday season. Cochrane notes the Federal Reserve faces a challenging policy dilemma: tariffs increase prices, yet there is mounting political pressure to lower interest rates. He characterizes tariffs as a potentially costly geopolitical weapon with uncertain strategic benefits. 1917

The John Batchelor Show
38: Tariffs as a Consumer Tax and the Inflationary Impact Guest: Professor John Cochrane Professor John Cochrane explains that tariffs effectively function as a tax on American consumers and create a temporary bump in inflation throughout the economy. Ret

The John Batchelor Show

Play Episode Listen Later Oct 29, 2025 4:56


    Tariffs as a Consumer Tax and the Inflationary Impact Guest: Professor John Cochrane Professor John Cochrane explains that tariffs effectively function as a tax on American consumers and create a temporary bump in inflation throughout the economy. Retailers are currently absorbing substantial cost increases but will likely pass these expenses on to consumers after the Christmas holiday season. Cochrane notes the Federal Reserve faces a challenging policy dilemma: tariffs increase prices, yet there is mounting political pressure to lower interest rates. He characterizes tariffs as a potentially costly geopolitical weapon with uncertain strategic benefits.

The John Batchelor Show
39: SHOW 10-28-25 CBS EYE ON THE WORLD WITH JOHN BATCHELOR THE SHOW BEGINS IN THE DOUBTS ABOUT AI AND JOBLESSNESS. FIRST HOUR 9-915 Market Relief, AI Layoffs, and Political Turmoil Guest: Elizabeth Peek Elizabeth Peek analyzes market relief followin

The John Batchelor Show

Play Episode Listen Later Oct 29, 2025 5:35


SHOW 10-28-25 CBS EYE ON THE WORLD WITH JOHN BATCHELOR 1920 FORDS THE SHOW BEGINS IN THE DOUBTS ABOUT AI AND JOBLESSNESS. FIRST HOUR 9-915 Market Relief, AI Layoffs, and Political Turmoil Guest: Elizabeth Peek Elizabeth Peek analyzes market relief following the temporary US-China trade truce, noting that President Trump effectively uses American consumer spending and tariff policy as a powerful geopolitical weapon. However, she expresses serious alarm over AI-driven mass layoffs across major corporations, including Amazon, coupled with a notable absence of substantive political debate addressing workforce displacement. Peek warns that the rise of an inexperienced, anti-capitalist mayoral candidate threatens New York City's economic prosperity and competitiveness in an increasingly challenging urban landscape. 915-930 Market Relief, AI Layoffs, and Political Turmoil Guest: Elizabeth Peek Elizabeth Peek analyzes market relief following the temporary US-China trade truce, noting that President Trump effectively uses American consumer spending and tariff policy as a powerful geopolitical weapon. However, she expresses serious alarm over AI-driven mass layoffs across major corporations, including Amazon, coupled with a notable absence of substantive political debate addressing workforce displacement. Peek warns that the rise of an inexperienced, anti-capitalist mayoral candidate threatens New York City's economic prosperity and competitiveness in an increasingly challenging urban landscape. 930-945 Gaza Conflict Persists and Iran's Nuclear Threat Revived Guest: Jonathan Schanzer Jonathan Schanzer confirms the Gaza conflict continues unabated, with Israel responding to ongoing Hamas attacks while Hamas deliberately slow-rolls hostage returns to maintain negotiating leverage. Hamas's fighting force is now commanded by inexperienced officers and young combatants operating in shrinking territory with diminishing resources. Schanzer also addresses alarming reports that Iran is rebuilding a suspect nuclear enrichment site, underscoring that maintaining peace requires constant vigilance and sustained pressure against malevolent actors determined to destabilize the region. 945-1000 Gaza Conflict Persists and Iran's Nuclear Threat Revived Guest: Jonathan Schanzer Jonathan Schanzer confirms the Gaza conflict continues unabated, with Israel responding to ongoing Hamas attacks while Hamas deliberately slow-rolls hostage returns to maintain negotiating leverage. Hamas's fighting force is now commanded by inexperienced officers and young combatants operating in shrinking territory with diminishing resources. Schanzer also addresses alarming reports that Iran is rebuilding a suspect nuclear enrichment site, underscoring that maintaining peace requires constant vigilance and sustained pressure against malevolent actors determined to destabilize the region. SECOND HOUR 10-1015 Tariffs as a Consumer Tax and the Inflationary Impact Guest: Professor John Cochrane Professor John Cochrane explains that tariffs effectively function as a tax on American consumers and create a temporary bump in inflation throughout the economy. Retailers are currently absorbing substantial cost increases but will likely pass these expenses on to consumers after the Christmas holiday season. Cochrane notes the Federal Reserve faces a challenging policy dilemma: tariffs increase prices, yet there is mounting political pressure to lower interest rates. He characterizes tariffs as a potentially costly geopolitical weapon with uncertain strategic benefits. 1015-1030 Tariffs as a Consumer Tax and the Inflationary Impact Guest: Professor John Cochrane Professor John Cochrane explains that tariffs effectively function as a tax on American consumers and create a temporary bump in inflation throughout the economy. Retailers are currently absorbing substantial cost increases but will likely pass these expenses on to consumers after the Christmas holiday season. Cochrane notes the Federal Reserve faces a challenging policy dilemma: tariffs increase prices, yet there is mounting political pressure to lower interest rates. He characterizes tariffs as a potentially costly geopolitical weapon with uncertain strategic benefits. 1030-1045 UK "Chinese Spy" Case Collapses and Trump's Trade Deal Outcomes Guest: Joseph Sternberg Joseph Sternberg discusses the collapse of the United Kingdom's high-profile Chinese espionage case involving Chris Cash and Chris Barry, highlighting the injustice of a media-driven trial despite allegations never being proven in court. The alleged intelligence supposedly passed was largely parliamentary rumors of minimal significance. Sternberg expresses disappointment with President Trump's temporary trade concessions from China, characterizing the outcome as underwhelming and questioning whether the deal achieves meaningful geopolitical objectives. 1045-1100 UK "Chinese Spy" Case Collapses and Trump's Trade Deal Outcomes Guest: Joseph Sternberg Joseph Sternberg discusses the collapse of the United Kingdom's high-profile Chinese espionage case involving Chris Cash and Chris Barry, highlighting the injustice of a media-driven trial despite allegations never being proven in court. The alleged intelligence supposedly passed was largely parliamentary rumors of minimal significance. Sternberg expresses disappointment with President Trump's temporary trade concessions from China, characterizing the outcome as underwhelming and questioning whether the deal achieves meaningful geopolitical objectives.THIRD HOUR 1100-1115 China's Weakness and Global Geopolitical Shifts Guest: Gregory Copley Gregory Copley assesses the strategic implications of President Trump's Asia trip amid China's accelerating economic and political collapse. He notes Xi Jinping's apparent loss of consolidated power and the disarray within the People's Liberation Army command structure. Copley discusses emerging US and allied rare earth supply agreements designed to counter Chinese leverage in critical materials markets. He also highlights Turkey's continuing role in prolonging the Gaza conflict and analyzes the broader shift toward conservative, market-oriented governance across Latin America. 1115-1130 China's Weakness and Global Geopolitical Shifts Guest: Gregory Copley Gregory Copley assesses the strategic implications of President Trump's Asia trip amid China's accelerating economic and political collapse. He notes Xi Jinping's apparent loss of consolidated power and the disarray within the People's Liberation Army command structure. Copley discusses emerging US and allied rare earth supply agreements designed to counter Chinese leverage in critical materials markets. He also highlights Turkey's continuing role in prolonging the Gaza conflict and analyzes the broader shift toward conservative, market-oriented governance across Latin America. 1130-1145 China's Weakness and Global Geopolitical Shifts Guest: Gregory Copley Gregory Copley assesses the strategic implications of President Trump's Asia trip amid China's accelerating economic and political collapse. He notes Xi Jinping's apparent loss of consolidated power and the disarray within the People's Liberation Army command structure. Copley discusses emerging US and allied rare earth supply agreements designed to counter Chinese leverage in critical materials markets. He also highlights Turkey's continuing role in prolonging the Gaza conflict and analyzes the broader shift toward conservative, market-oriented governance across Latin America. 1145-1200 China's Weakness and Global Geopolitical Shifts Guest: Gregory Copley Gregory Copley assesses the strategic implications of President Trump's Asia trip amid China's accelerating economic and political collapse. He notes Xi Jinping's apparent loss of consolidated power and the disarray within the People's Liberation Army command structure. Copley discusses emerging US and allied rare earth supply agreements designed to counter Chinese leverage in critical materials markets. He also highlights Turkey's continuing role in prolonging the Gaza conflict and analyzes the broader shift toward conservative, market-oriented governance across Latin America. FOURTH HOUR 12-1215 Proliferation Risks from US Surplus Plutonium Sales Guest: Henry Sokolski Henry Sokolski critiques the Department of Energy's plan to sell 20 tons of surplus weapons-grade plutonium to American firms for use in new reactor designs. He warns that promoting plutonium fuel exports substantially raises international proliferation risks by bringing nations substantially closer to nuclear weapons capability. Sokolski notes that South Korea is actively seeking permission to recycle plutonium domestically, a development that increases nuclear uncertainty across the Korean Peninsula and challenges the global nonproliferation regime. 1215-1230 Google's Quantum Leap and the Advancing AI Frontier Guest: Brandon Weichert Brandon Weichert discusses Google's Willow quantum chip, which has achieved verifiable quantum advantage, surpassing supercomputers by a factor of 13,000. This breakthrough contrasts sharply with Microsoft's contested Majorana chip, which remains unproven. Weichert notes the rapid evolution of AI systems, including Grok and ChatGPT, each advancing in sophistication at an accelerating pace. He emphasizes that the future demands pairing artificial intelligence with quantum technology to unlock transformative computational capabilities beyond current limitations. 1230-1245 Strengthening the US-Japan Alliance and Rare Earth Supply Guest: Grant Newsham Grant Newsham analyzes the successful meeting between President Trump and Japan's newly appointed Prime Minister, Takayuki Sai. The two leaders agreed on rare earth supply cooperation, crucial for countering Chinese economic leverage and maintaining technological independence. Sai is focused on substantially increasing Japan's defense spending and addressing military recruitment shortfalls to strengthen regional capability. The United States values Japan's defensive posture as a critical bulwark against the People's Republic of China, making this alliance essential for Indo-Pacific stability. 1245-100 AM Strengthening the US-Japan Alliance and Rare Earth Supply Guest: Grant Newsham Grant Newsham analyzes the successful meeting between President Trump and Japan's newly appointed Prime Minister, Takayuki Sai. The two leaders agreed on rare earth supply cooperation, crucial for countering Chinese economic leverage and maintaining technological independence. Sai is focused on substantially increasing Japan's defense spending and addressing military recruitment shortfalls to strengthen regional capability. The United States values Japan's defensive posture as a critical bulwark against the People's Republic of China, making this alliance essential for Indo-Pacific stability.

The John Batchelor Show
1: SHOW SCHEDULE 10-15--25 CBS EYE ON THE WORLD WITH JOHN BATCHELOR 1964 ATLANTIC CITYCONVENTION HALL THE SHOW BEGINS IN THE DOUBTS ABOUT CONGRESS.... 10-15--25 FIRST HOUR 9-915 HEADLINE: Obamacare Subsidies Trigger Government Shutdown Debate GUEST

The John Batchelor Show

Play Episode Listen Later Oct 16, 2025 5:56


SHOW SCHEDULE 10-15--25 CBS EYE ON THE WORLD WITH JOHN BATCHELOR 1964 ATLANTIC CITYCONVENTION HALL THE SHOW BEGINS IN THE DOUBTS ABOUT CONGRESS.... 10-15--25 FIRST HOUR 9-915 HEADLINE: Obamacare Subsidies Trigger Government Shutdown Debate GUEST NAME: Michael Toth SUMMARY: Michael Toth explains that the current government shutdown debate centers on extending two expensive Biden-era Obamacare subsidies. These changes allow individuals earning over 400% of the federal poverty line to receive subsidies and provide 100% coverage for the near-poor. The original Obamacare cross-subsidy structure failed because young, healthy individuals found premiums too high. Toth advocates deregulation, such as allowing insurance companies to charge lower, risk-adjusted rates and enabling single business owners to use Professional Employer Organizations (PEOs) for cheaper coverage. 915-930 HEADLINE: Obamacare Subsidies Trigger Government Shutdown Debate GUEST NAME: Michael Toth SUMMARY: Michael Toth explains that the current government shutdown debate centers on extending two expensive Biden-era Obamacare subsidies. These changes allow individuals earning over 400% of the federal poverty line to receive subsidies and provide 100% coverage for the near-poor. The original Obamacare cross-subsidy structure failed because young, healthy individuals found premiums too high. Toth advocates deregulation, such as allowing insurance companies to charge lower, risk-adjusted rates and enabling single business owners to use Professional Employer Organizations (PEOs) for cheaper coverage. 930-945 HEADLINE: Hamas, Hostages, and Middle East Turmoil: Challenges to the Trump Ceasefire Plan GUEST NAME:Jonathan Schanzer SUMMARY: Jonathan Schanzer discusses complications in the Trump ceasefire plan, including Hamas delaying the return of deceased hostages to maintain leverage. The released prisoners, including potential Hamas leaders, raise concerns about where the organization's center of gravity will shift if they are deported to places like Turkey or Qatar. Schanzer views Turkey, an autocratic supporter of Hamas, as a problematic guarantor of the ceasefire. Internationally, Iran continues its nuclear program despite snapback sanctions, and al-Sharaa is meeting with Putin regarding Russian assets in Syria. 945-1000 HEADLINE: Hamas, Hostages, and Middle East Turmoil: Challenges to the Trump Ceasefire Plan GUEST NAME:Jonathan Schanzer SUMMARY: Jonathan Schanzer discusses complications in the Trump ceasefire plan, including Hamas delaying the return of deceased hostages to maintain leverage. The released prisoners, including potential Hamas leaders, raise concerns about where the organization's center of gravity will shift if they are deported to places like Turkey or Qatar. Schanzer views Turkey, an autocratic supporter of Hamas, as a problematic guarantor of the ceasefire. Internationally, Iran continues its nuclear program despite snapback sanctions, and al-Sharaa is meeting with Putin regarding Russian assets in Syria. SECOND HOUR 10-1015 HEADLINE: China's Predicament in the Middle East and Domestic Economic Instability GUEST NAME: General Blaine Holt SUMMARY: General Blaine Holt analyzes China's strategic challenges, noting Beijing is concerned about losing access to critical oil and gas resources as US leadership advances the Abraham Accords. China's previous regional deals, like the Saudi-Iran agreement, lacked substance compared to US business commitments. Holt suggests internal pressures might lead Iran toward the Accords. Domestically, China faces accelerating deflation and uncertainty regarding Xi Jinping's leadership due to four competing factions before the fourth plenum. 1015-1030 HEADLINE: South Korea's Descent into Authoritarianism and Persecution of Opposition GUEST NAME: Morse Tan SUMMARY: Morse Tan argues that South Korea is moving toward a "rising communist dictatorship" that oppresses political and religious figures. The indictment of the Unification Church leader and the targeting of the rightful President Yoon exemplify this trend. This persecution serves as an intimidation campaign, demonstrating the regime's disregard for the populace. Tan recommends the US implement active measures, including sanctions relating to a coup d'état and visa sanctions, while also pressing for greater military cooperation. 1030-1045 HEADLINE: Russian War Economy Stalls as Oil Prices Decline and Sanctions Bite GUEST NAME: Michael Bernstam SUMMARY: Michael Bernstam reports that the Russian economy is struggling as global oil prices decline and sanctions increase transportation costs, leading to a $13 to $14 per barrel discount on Russian oil. The "military Keynesianism" economy is exhausted, resulting in staff cuts across industrial sectors. Forecasts indicate contraction in late 2025 and 2026, with the IMF lowering its growth projection for 2025 to 0.6%. Russia is avoiding sanctions by routing payments through neighbors like Kyrgyzstan, who have become major financial hubs. 1045-1100 HEADLINE: Lessons from the Swiss National Bank: Risk-Taking, Exchange Rates, and Fiscal Responsibility GUEST NAME: John Cochrane SUMMARY: Economist John Cochrane analyzes the Swiss National Bank (SNB), noting it differs greatly from the US Federal Reserve by investing heavily in foreign stocks and bonds to manage the Swiss franc's exchange rate. The SNB's massive balance sheet carries risks accepted by Swiss taxpayers and the Cantons. Switzerland, being fiscally responsible (running no budget deficits), finds central banking easier. Cochrane advises that the US Fed should not be buying stocks or venturing into fiscal policy. THIRD HOUR 1100-1115 HEADLINE: China Retaliates Against Dutch Chipmaker Seizure Amid European Fragmentation GUEST NAME:Theresa Fallon SUMMARY: Theresa Fallon discusses China imposing export controls on Nexperia after the Dutch government seized control of the chipmaker, which was owned by China's Wingtech. The Dutch acted due to fears the Chinese owner would strip the technology and equipment, despite Nexperia producing low-quality chips for cars. Fallon notes Europe needs a better chip policy but struggles to speak with one voice, as fragmented policy allows China to drive wedges and weaken the EU. 1115-1130 HEADLINE: China's Economic Slowdown, Deflation, and the Spectre of Japanification GUEST NAME: Andrew Collier SUMMARY: Andrew Collier discusses China's economic woes, characterized by persistent deflation, with the CPI down 0.3% (6 out of 9 months in the red) and the PPI down for 36 straight months. This environment raises concerns about "Japanification"—a multi-decade slowdown after a property crash. Major structural changes to stimulate consumer consumption are unlikely at the upcoming Communist Party plenum, as the system favors state investment. The property market collapse means foreign investment is leaving, and Collier suggests the economy may not bottom until 2027 or 2028. 1130-1145 HEADLINE: SpaceX Starship Success, Private Space Dominance, and Government Inaction GUEST NAME: Bob Zimmerman SUMMARY: Bob Zimmerman describes SpaceX's Starship Super Heavy 11th test flight as "remarkable," highlighting successful booster reuse and controlled re-entry despite missing tiles. He asserts that private enterprise, like SpaceX, runs the "real American space program" aimed at Mars colonization, outpacing government efforts. In contrast, European projects like Callisto, proposed in 2015, demonstrate government "inaction." JPL is also laying off staff following the cancellation of the Mars sample return project, forcing organizations like Lowell Observatory to seek private funding. 1145-1200 HEADLINE: SpaceX Starship Success, Private Space Dominance, and Government Inaction GUEST NAME: Bob Zimmerman SUMMARY: Bob Zimmerman describes SpaceX's Starship Super Heavy 11th test flight as "remarkable," highlighting successful booster reuse and controlled re-entry despite missing tiles. He asserts that private enterprise, like SpaceX, runs the "real American space program" aimed at Mars colonization, outpacing government efforts. In contrast, European projects like Callisto, proposed in 2015, demonstrate government "inaction." JPL is also laying off staff following the cancellation of the Mars sample return project, forcing organizations like Lowell Observatory to seek private funding. FOURTH HOUR 12-1215 HEADLINE: Commodity Market Trends and UK's Lack of Risk Appetite for AI Innovation GUEST NAME: Simon Constable SUMMARY: Simon Constable notes that data center expansion for AI is increasing prices for copper (up 15%) and steel (up 14%). He points out that the UK lags significantly behind the US in building new AI data centers (170 vs. 5,000+) due to a lack of risk appetite, insufficient wealth, and poor marketing of new ideas. Separately, Constable discusses the collapse of a UK China spying trial because the prior government failed to officially classify China as a national security threat during the alleged offenses. 1215-1230 HEADLINE: Commodity Market Trends and UK's Lack of Risk Appetite for AI Innovation GUEST NAME: Simon Constable SUMMARY: Simon Constable notes that data center expansion for AI is increasing prices for copper (up 15%) and steel (up 14%). He points out that the UK lags significantly behind the US in building new AI data centers (170 vs. 5,000+) due to a lack of risk appetite, insufficient wealth, and poor marketing of new ideas. Separately, Constable discusses the collapse of a UK China spying trial because the prior government failed to officially classify China as a national security threat during the alleged offenses. 1230-1245 HEADLINE: AI Regulation Debate: Premature Laws vs. Emerging Norms GUEST NAME: Kevin Frazier SUMMARY: Kevin Frazier critiques the legislative rush to regulate AI, arguing that developing norms might be more effective than premature laws. He notes that bills like California's AB 1047, which demands factual accuracy, fundamentally misunderstand AI's generative nature. Imposing vague standards, as seen in New York's RAISE Act, risks chilling innovation and preventing widespread benefits, like affordable legal or therapy tools. Frazier emphasizes that AI policy should be grounded in empirical data rather than speculative fears. 1245-100 AM HEADLINE: AI Regulation Debate: Premature Laws vs. Emerging Norms GUEST NAME: Kevin Frazier SUMMARY: Kevin Frazier critiques the legislative rush to regulate AI, arguing that developing norms might be more effective than premature laws. He notes that bills like California's AB 1047, which demands factual accuracy, fundamentally misunderstand AI's generative nature. Imposing vague standards, as seen in New York's RAISE Act, risks chilling innovation and preventing widespread benefits, like affordable legal or therapy tools. Frazier emphasizes that AI policy should be grounded in empirical data rather than speculative fears.

The John Batchelor Show
HEADLINE: Lessons from the Swiss National Bank: Risk-Taking, Exchange Rates, and Fiscal Responsibility GUEST NAME: John Cochrane SUMMARY: Economist John Cochrane analyzes the Swiss National Bank (SNB), noting it differs greatly from the US Federal Reserve

The John Batchelor Show

Play Episode Listen Later Oct 16, 2025 10:55


HEADLINE: Lessons from the Swiss National Bank: Risk-Taking, Exchange Rates, and Fiscal Responsibility GUEST NAME: John Cochrane SUMMARY: Economist John Cochrane analyzes the Swiss National Bank (SNB), noting it differs greatly from the US Federal Reserve by investing heavily in foreign stocks and bonds to manage the Swiss franc's exchange rate. The SNB's massive balance sheet carries risks accepted by Swiss taxpayers and the Cantons. Switzerland, being fiscally responsible (running no budget deficits), finds central banking easier. Cochrane advises that the US Fed should not be buying stocks or venturing into fiscal policy. 1890 SWISS